FPGEE Practice Test

Foreign Pharmacy Graduate Equivalency Examination

FPGEE overview

  • 200 practice questions
  • 32 flashcards
  • 5 study guide topics
  • 37 key terms

What you'll study

  • Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)25%
  • Pharmacology, Medicinal Chemistry, and Toxicology20%
  • Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)30%
  • Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)15%
  • Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)10%

The Foreign Pharmacy Graduate Equivalency Examination (FPGEE) is the assessment the National Association of Boards of Pharmacy (NABP) uses to judge whether a pharmacist educated outside the United States holds knowledge comparable to that of a US-educated entry-level practitioner. Passing it is not a license: it is one step that foreign graduates complete before a state or territorial board of pharmacy will consider them for licensure, along with whatever other requirements that board sets.

The exam is multiple choice and samples broadly across the pharmacy curriculum. Expect foundational biomedical and pharmaceutical sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics); pharmacology, medicinal chemistry and toxicology; a large clinical pharmacy and pharmacotherapy component covering patient assessment, monitoring and drug information; social, behavioral, administrative and economic sciences; and pharmacy practice, law, ethics and compounding. Items are rarely pure recall - most ask you to apply a principle to a patient scenario.

Preparation rewards structure over volume. Obtain NABP's current content outline, map a study calendar to its domains, audit your weakest areas first, review foundational sciences before therapeutics so mechanisms and kinetics make sense, then finish with timed vignette-style practice in which you justify every choice. This page is independent study material and is not affiliated with or endorsed by NABP.

Common mistakes

Computing pharmacokinetic parameters (half-life, clearance, Vd, AUC) from raw numbers without first writing the governing equation and checking unit consistency, so a value in mg is divided by a value in mcg/mL.

Candidates memorize formulas as strings of symbols and rush to plug in numbers under time pressure, treating unit conversion as an afterthought.

What to do instead

Before any calculation, write the equation, list each variable with its unit, and convert everything to a single system (mg, L, hr) in a scratch column. Sanity-check the answer against a known order of magnitude (e.g., a normal half-life in hours, not milliseconds).

Confusing zero-order and first-order elimination when asked about changes in half-life or time to steady state after a dose adjustment.

The two processes are memorized as parallel facts rather than as distinct mathematical behaviors (constant amount vs. constant fraction removed per unit time).

What to do instead

Anchor each concept to its signature: in first-order, half-life is dose-independent and steady state takes ~4-5 half-lives; in zero-order (e.g., phenytoin, ethanol at high concentrations), a small dose increase can produce a disproportionate, nonlinear rise in concentration. Practice predicting the direction of change before calculating.

Selecting a drug on the basis of a remembered indication without screening it against the patient's comorbidities, renal/hepatic function, pregnancy status, or interacting medications presented in the vignette.

Vignettes are read for the chief complaint only; candidates pattern-match "diagnosis to drug" and skip the rest of the stem, which is where the discriminating details live.

What to do instead

Adopt a fixed vignette-reading sequence: extract age, weight, pregnancy/lactation, renal and hepatic function, allergies, current medications, and abnormal labs into a short list before looking at the options, then eliminate any option that fails one of those constraints.

Applying the same starting dose or monitoring plan to special populations (elderly, pediatric, obese, dialysis, hepatic impairment) as to a general adult.

Dosing tables are studied for the standard adult and the adjustment rules are treated as optional trivia rather than as the core of the question.

What to do instead

For every pharmacotherapy question, explicitly ask "what is different about this patient?" and route through a mental checklist: weight-based vs. fixed dosing, renal dose adjustment, hepatic metabolism, Beers criteria for the elderly, and altered volume of distribution in obesity or ascites.

Answering drug-information questions by recalling the answer directly instead of identifying the appropriate tertiary, secondary, or primary source and the correct evaluation hierarchy.

Candidates conflate "what is the answer" with "how should this question be answered," and study drug facts while neglecting the structure of the literature.

What to do instead

Learn source categories by example: tertiary (compendia, DI databases, guidelines), secondary (indexing/abstracting services such as PubMed or Iowa Drug Information Service), primary (original research). When asked for the best resource, first classify the question type (dosing, compatibility, adverse event, primary literature) and match it to that tier.

Misreading a federal law question by mixing up which statute governs which activity - for example, treating the Poison Prevention Packaging Act, the Durham-Humphrey Amendment, the Kefauver-Harris Amendment, and the Combat Methamphetamine Epidemic Act as interchangeable.

The amendments are memorized as a list of names and years with weak linkage to the specific obligation each one creates for the pharmacist.

What to do instead

Build a statute-to-duty table with one column per law and one row per real task (child-resistant packaging, oral prescription status, proof of efficacy before marketing, PSE sales limits and logbooks, REMS, compounding oversight under 503A/503B). Test yourself by task, not by law name.

Treating compounding standards as optional best practice rather than as enforceable requirements, and answering questions about beyond-use dates, sterile technique, or prescription requirements from general intuition.

Compounding is often studied last and from summaries, so USP <795>/<797> categories, beyond-use dating logic, and the 503A vs. 503B distinction are fuzzy.

What to do instead

Memorize the framework rather than individual numbers: risk levels for sterile compounding (low, medium, high) with their corresponding beyond-use dates and environments, the water-source and purity requirements for nonsterile vs. sterile preparations, and the criteria that make a compound eligible for 503A (patient-specific prescription, licensed pharmacist, compliance with USP).

Answering pharmacoeconomic questions with a vague sense of cost rather than by classifying the analysis (cost-minimization, cost-effectiveness, cost-utility, cost-benefit, cost-of-illness) and identifying its outcome unit.

The types are memorized as similar-sounding names without the outcome-unit discriminator that actually defines them.

What to do instead

Attach each type to its outcome: dollars only (cost-minimization), natural clinical units such as mm Hg or life-years gained (cost-effectiveness), quality-adjusted life-years (cost-utility), and dollar-valued outcomes with a net benefit or benefit-to-cost ratio (cost-benefit). Read the denominator of the ratio in the question stem first - it usually names the analysis outright.

Interpreting a study result as clinically meaningful without checking the confidence interval, absolute rather than relative risk reduction, number needed to treat, and whether the endpoint was a surrogate or a hard outcome.

Headlines and abstract conclusions emphasize relative risk and p-values, and candidates carry that framing into the exam.

What to do instead

For every study question, compute or compare absolute risk reduction (control rate minus treatment rate) and NNT (1/ARR) alongside the relative reduction, and check whether the confidence interval crosses the null. Flag any endpoint that is a lab value or biomarker rather than mortality, stroke, or hospitalization.

Missing questions on mechanism and structure-activity relationships because drugs are memorized by name and class rather than by target, functional group, and metabolic soft spot.

Medicinal chemistry is treated as rote nomenclature, so questions that present an unfamiliar structure or ask why a structural change alters potency, duration, or toxicity have no scaffold to hang on.

What to do instead

Study each class around a core pharmacophore: identify the target (receptor, enzyme, transporter), the key binding or reactive groups, and the metabolic or excretion route that drives duration and interactions. Practice predicting the consequence of a single structural change (adding a hydroxyl, replacing a methyl, halogenating an aromatic ring) on lipophilicity, half-life, and receptor affinity before looking at the answer choices.

Exam requirements can change. Confirm current details with the exam provider.

FPGEE practice

200 questions. Each one lists the choices, the correct answer, and an explanation. With JavaScript, this list opens one question at a time. The checker at the top of this page saves progress in this browser when it is available.

  1. Question 1Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    In Michaelis–Menten kinetics, what does the Km value represent?

    1. The rate constant for dissociation of the enzyme–product complex
    2. The enzyme concentration needed to achieve maximal velocity
    3. The substrate concentration at which velocity is half of Vmax Correct answer.
    4. The maximal velocity reached when the enzyme is saturated

    Explanation

    Km is the substrate concentration at which the reaction proceeds at one-half of Vmax, so it has units of concentration. A low Km indicates high apparent affinity of the enzyme for the substrate.

  2. Question 2Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Beta-lactam antibiotics such as penicillin produce their antibacterial effect by interfering with which process?

    1. Cross-linking of peptidoglycan by transpeptidases Correct answer.
    2. Assembly of the 50S ribosomal subunit
    3. Conversion of para-aminobenzoic acid to tetrahydrofolate
    4. Supercoiling of bacterial DNA

    Explanation

    Beta-lactams acylate the active-site serine of penicillin-binding proteins, which are transpeptidases that cross-link peptidoglycan strands. Loss of cross-linking weakens the wall and leads to lysis of actively dividing bacteria.

  3. Question 3Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which immunoglobulin class is transported across the placenta and supplies most of the newborn's passive humoral immunity?

    1. IgG Correct answer.
    2. IgA
    3. IgM
    4. IgE

    Explanation

    IgG is captured by the neonatal Fc receptor on syncytiotrophoblasts and actively transported into fetal circulation, peaking in the third trimester. This transfer gives the infant temporary protection against many systemic pathogens.

  4. Question 4Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which route of administration is assumed by definition to give 100% bioavailability?

    1. Transdermal patch
    2. Intravenous bolus Correct answer.
    3. Oral tablet
    4. Rectal suppository

    Explanation

    Bioavailability is defined relative to the intravenous dose, because drug injected directly into the systemic circulation escapes absorption and first-pass hepatic metabolism. All extravascular routes yield a fraction less than one.

  5. Question 5Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    In bacteria, which enzyme catalyzes synthesis of an RNA copy from a DNA template?

    1. RNA polymerase Correct answer.
    2. DNA polymerase III
    3. Reverse transcriptase
    4. Primase

    Explanation

    DNA-dependent RNA polymerase binds the promoter, unwinds DNA and polymerizes ribonucleotides complementary to the template strand. In prokaryotes the same core enzyme transcribes mRNA, tRNA and rRNA.

  6. Question 6Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which excipient serves as a binder in a wet-granulated tablet formulation?

    1. Croscarmellose sodium
    2. Magnesium stearate
    3. Colloidal silicon dioxide
    4. Povidone Correct answer.

    Explanation

    Povidone is a hydrophilic polymer added as a granulating solution or dry powder to promote adhesion of particles within granules. It improves granule strength and tablet compactibility.

  7. Question 7Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which vitamin is required as a cofactor for gamma-carboxylation of glutamate residues in clotting factors II, VII, IX and X?

    1. Folic acid
    2. Vitamin K Correct answer.
    3. Thiamine
    4. Ascorbic acid

    Explanation

    Vitamin K hydroquinone is the cofactor for the vitamin K-dependent carboxylase that converts specific glutamate residues to gamma-carboxyglutamate. These residues bind calcium and allow the factors to assemble on phospholipid membranes.

  8. Question 8Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which organism appears as Gram-positive cocci in clusters and is catalase-positive?

    1. Staphylococcus aureus Correct answer.
    2. Neisseria meningitidis
    3. Streptococcus pyogenes
    4. Escherichia coli

    Explanation

    Staphylococci are Gram-positive cocci arranged in grape-like clusters and, unlike streptococci, produce catalase. This combination distinguishes them from the catalase-negative streptococci in chains.

  9. Question 9Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A drug is eliminated by first-order kinetics with a half-life of 6 hours. Approximately what percentage of an intravenous dose remains in the body 24 hours after administration?

    1. 3.1%
    2. 25%
    3. 6.25% Correct answer.
    4. 12.5%

    Explanation

    Twenty-four hours corresponds to four half-lives, and the fraction remaining is (1/2)^4 = 1/16, or 6.25% of the dose. Each half-life halves whatever amount is present.

  10. Question 10Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A 500 mg intravenous bolus of a drug produces an immediate plasma concentration of 25 mg/L before any elimination occurs. What is the apparent volume of distribution?

    1. 0.05 L
    2. 5 L
    3. 20 L Correct answer.
    4. 12,500 L

    Explanation

    Volume of distribution equals dose divided by the extrapolated initial concentration: 500 mg ÷ 25 mg/L = 20 L. The value is apparent because it assumes instantaneous and uniform distribution.

  11. Question 11Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    When one molecule of glucose is converted to two molecules of pyruvate in glycolysis, what is the net yield of ATP?

    1. Zero
    2. One
    3. Two Correct answer.
    4. Four

    Explanation

    Four ATP molecules are generated at the phosphoglycerate kinase and pyruvate kinase steps, but two ATP are consumed by hexokinase and phosphofructokinase-1. The net yield is therefore two ATP per glucose.

  12. Question 12Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which enzyme catalyzes the rate-limiting, committed step of the urea cycle?

    1. Ornithine transcarbamoylase
    2. Carbamoyl phosphate synthetase I Correct answer.
    3. Arginase
    4. Argininosuccinate lyase

    Explanation

    Carbamoyl phosphate synthetase I in the mitochondrial matrix forms carbamoyl phosphate from ammonia and bicarbonate and is activated by N-acetylglutamate. This step is both rate-limiting and committed, since carbamoyl phosphate enters essentially only this pathway.

  13. Question 13Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Peptides derived from proteins synthesized inside a cell are displayed on the surface by which molecule, and recognized by which cell type?

    1. MHC class I, recognized by CD8+ T cells Correct answer.
    2. MHC class II, recognized by CD8+ T cells
    3. MHC class II, recognized by CD4+ T cells
    4. MHC class I, recognized by CD4+ T cells

    Explanation

    Endogenous cytosolic proteins are degraded by the proteasome, transported into the endoplasmic reticulum and loaded onto MHC class I molecules. The resulting complex is recognized by the CD8 coreceptor-bearing cytotoxic T cells.

  14. Question 14Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which cytokine acts as the principal endogenous pyrogen in the febrile response?

    1. Transforming growth factor beta
    2. Interleukin-10
    3. Interleukin-4
    4. Interleukin-1 beta Correct answer.

    Explanation

    Interleukin-1 beta released by activated macrophages acts on the hypothalamus to raise the set point, largely through increased prostaglandin E2 synthesis. Interleukin-6 and TNF also contribute to fever.

  15. Question 15Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    The minimum inhibitory concentration of an antimicrobial is defined as which of the following?

    1. The highest serum concentration tolerated without toxicity
    2. The lowest concentration that prevents visible growth Correct answer.
    3. The steady-state concentration reached after repeated dosing
    4. The lowest concentration that kills 99.9% of the inoculum

    Explanation

    The MIC is determined by broth or agar dilution and is the lowest drug concentration that suppresses visible turbidity after a defined incubation period. It is a measure of growth inhibition, not of killing.

  16. Question 16Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Vancomycin interferes with bacterial cell wall assembly by which mechanism?

    1. Inhibiting DNA topoisomerase IV
    2. Acylating transpeptidases after ring opening
    3. Binding the D-alanyl-D-alanine terminus of peptidoglycan precursors Correct answer.
    4. Blocking translocation at the 50S ribosomal subunit

    Explanation

    Vancomycin is a glycopeptide that hydrogen-bonds to the D-Ala-D-Ala end of lipid-linked precursors, preventing their incorporation and cross-linking. Because it acts at the substrate rather than the enzyme, it is not hydrolyzed by beta-lactamases.

  17. Question 17Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which statement describes zero-order elimination of a drug?

    1. A constant fraction of the drug in the body is removed per unit time
    2. The half-life is independent of the dose administered
    3. Clearance rises in proportion to plasma concentration
    4. A constant amount of drug is removed per unit time Correct answer.

    Explanation

    In zero-order kinetics the eliminating processes are saturated, so a fixed quantity is removed per unit time regardless of concentration. Because the amount removed is constant while the body burden falls, the half-life lengthens as concentration declines.

  18. Question 18Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Under standard regulatory criteria, the 90% confidence interval for the ratio of AUC and Cmax of a generic product versus the reference product should fall within which range?

    1. 80% to 125% Correct answer.
    2. 90% to 110%
    3. 95% to 105%
    4. 70% to 143%

    Explanation

    Average bioequivalence requires the 90% confidence interval for the geometric mean ratios of AUC and Cmax to lie within 0.80 to 1.25. This range is a statistical decision rule intended to limit the risk that a truly bioinequivalent product is declared equivalent.

  19. Question 19Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    In a standard polymerase chain reaction, what is the purpose of the annealing step?

    1. To extend primers with a thermostable polymerase
    2. To insert the product into a cloning vector
    3. To allow primers to bind complementary template sequences Correct answer.
    4. To separate double-stranded DNA into single strands

    Explanation

    After heat denaturation, the temperature is lowered so that short oligonucleotide primers hybridize to their complementary sequences flanking the target. The annealing temperature sets specificity and is usually a few degrees below the primer melting temperature.

  20. Question 20Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Dideoxynucleotides that terminate chain elongation are central to which technique?

    1. Quantitative real-time PCR
    2. Southern blotting
    3. Western blotting
    4. Dideoxy DNA sequencing Correct answer.

    Explanation

    In Sanger sequencing, incorporation of a dideoxynucleotide lacking a 3'-hydroxyl group blocks further extension, generating a family of fragments ending at each base position. Size separation of these fragments reveals the sequence.

  21. Question 21Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Classical phenylketonuria most often results from deficiency of which enzyme?

    1. Homogentisate oxidase
    2. Tyrosine aminotransferase
    3. Branched-chain alpha-ketoacid dehydrogenase
    4. Phenylalanine hydroxylase Correct answer.

    Explanation

    Phenylalanine hydroxylase converts phenylalanine to tyrosine using tetrahydrobiopterin; when it is deficient, phenylalanine accumulates and is transaminated to phenylketones. Untreated accumulation causes intellectual disability, which is why newborn screening and a low-phenylalanine diet are used.

  22. Question 22Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A drug has a hepatic extraction ratio of 0.9. Which statement about its disposition is most accurate?

    1. Its oral bioavailability is approximately 90%
    2. Its hepatic clearance is approximately equal to hepatic blood flow Correct answer.
    3. Doubling its intrinsic clearance will roughly double its hepatic clearance
    4. Its hepatic clearance is limited mainly by plasma protein binding

    Explanation

    For a drug with a high extraction ratio, the well-stirred model gives clearance close to liver blood flow, because the liver removes nearly all drug presented to it. Clearance is therefore flow-limited and relatively insensitive to changes in protein binding or intrinsic clearance, while oral bioavailability is only about 1 minus the extraction ratio, here 10%.

  23. Question 23Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    According to the Noyes–Whitney relationship, which change would most increase the dissolution rate of a poorly water-soluble drug?

    1. Reducing the particle size of the powder Correct answer.
    2. Decreasing the saturation solubility of the drug
    3. Increasing the thickness of the diffusion layer
    4. Increasing the viscosity of the dissolution medium

    Explanation

    Dissolution rate is proportional to the surface area available and to the concentration gradient across the boundary layer. Milling or micronizing the powder raises surface area substantially, which increases the dissolution rate.

  24. Question 24Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A young man develops acute hemolytic anemia after taking primaquine. Deficiency of which enzyme is most likely responsible, and through what immediate consequence?

    1. Hexokinase, causing impaired glucose trapping in erythrocytes
    2. Pyruvate kinase, causing impaired ATP generation
    3. Glucose-6-phosphatase, causing impaired gluconeogenesis
    4. Glucose-6-phosphate dehydrogenase, causing low NADPH and reduced glutathione Correct answer.

    Explanation

    Erythrocytes depend on the pentose phosphate pathway for NADPH, which keeps glutathione reduced and protects hemoglobin and membrane lipids from oxidation. In G6PD deficiency, oxidant drugs such as primaquine overwhelm these defenses and trigger intravascular hemolysis.

  25. Question 25Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Methicillin resistance in Staphylococcus aureus arises primarily through which mechanism?

    1. Overexpression of a multidrug efflux pump
    2. Production of a plasmid-encoded beta-lactamase
    3. Mutation of the 30S ribosomal subunit
    4. Acquisition of mecA encoding an altered penicillin-binding protein Correct answer.

    Explanation

    The mecA gene encodes PBP2a, a transpeptidase with low affinity for essentially all beta-lactams, so cell wall cross-linking continues despite drug exposure. Because methicillin is already beta-lactamase stable, enzymatic hydrolysis cannot explain the resistance.

  26. Question 26Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which enzyme catalyzes the rate-limiting, committed step of glycolysis?

    1. Pyruvate carboxylase
    2. Glucose-6-phosphate dehydrogenase
    3. Fructose-1,6-bisphosphatase
    4. Phosphofructokinase-1 Correct answer.

    Explanation

    Phosphofructokinase-1 converts fructose-6-phosphate to fructose-1,6-bisphosphate and is the committed, rate-limiting step of glycolysis. It is activated by AMP and fructose-2,6-bisphosphate and inhibited by ATP and citrate.

  27. Question 27Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which reaction of the citric acid cycle generates GTP by substrate-level phosphorylation?

    1. Malate to oxaloacetate
    2. Citrate to isocitrate
    3. Isocitrate to alpha-ketoglutarate
    4. Succinyl-CoA to succinate Correct answer.

    Explanation

    Succinyl-CoA synthetase couples cleavage of the thioester in succinyl-CoA to phosphorylation of GDP (or ADP), yielding GTP (or ATP) directly. All other steps of the cycle produce reduced coenzymes or carbon dioxide rather than a nucleoside triphosphate.

  28. Question 28Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Cyanide is rapidly lethal because it binds with high affinity to which component of the electron transport chain?

    1. Complex II
    2. ATP synthase
    3. Complex IV Correct answer.
    4. Complex I

    Explanation

    Cyanide binds the ferric heme iron of cytochrome c oxidase (Complex IV), blocking transfer of electrons to oxygen. Oxidative phosphorylation therefore stops and cells cannot regenerate ATP aerobically.

  29. Question 29Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which coenzyme is required by aminotransferases during transamination reactions?

    1. Thiamine pyrophosphate
    2. Biotin
    3. Tetrahydrofolate
    4. Pyridoxal phosphate Correct answer.

    Explanation

    Aminotransferases use pyridoxal phosphate, the active form of vitamin B6, as a coenzyme that shuttles amino groups between amino acids and alpha-keto acids. Without it, transfer of nitrogen from amino acids to alpha-ketoglutarate cannot occur.

  30. Question 30Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    During prolonged fasting the liver synthesizes ketone bodies but cannot use them for energy. Which statement best explains this?

    1. Hepatocytes lack acetyl-CoA carboxylase
    2. Hepatocytes lack carnitine palmitoyltransferase I
    3. Hepatocytes lack HMG-CoA synthase
    4. Hepatocytes lack thiophorase activity Correct answer.

    Explanation

    Peripheral tissues activate acetoacetate by transferring CoA from succinyl-CoA, a reaction catalyzed by thiophorase (succinyl-CoA:acetoacetate CoA transferase). The liver lacks this enzyme, so it exports ketone bodies instead of consuming them.

  31. Question 31Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which enzyme catalyzes the rate-limiting step of de novo fatty acid synthesis?

    1. HMG-CoA reductase
    2. Fatty acid synthase
    3. Acetyl-CoA carboxylase Correct answer.
    4. Carnitine palmitoyltransferase I

    Explanation

    Acetyl-CoA carboxylase converts acetyl-CoA to malonyl-CoA, committing carbon to fatty acid synthesis; it is the regulated, rate-limiting enzyme. It is activated by citrate and inhibited by palmitoyl-CoA.

  32. Question 32Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A neonate becomes lethargic and tachypneic after feeding. Plasma ammonia is markedly elevated, blood citrulline is low, and urinary orotic acid is high. Deficiency of which enzyme is most likely?

    1. Carbamoyl phosphate synthetase I
    2. Arginase
    3. Ornithine transcarbamylase Correct answer.
    4. Argininosuccinate lyase

    Explanation

    Ornithine transcarbamylase deficiency causes carbamoyl phosphate to accumulate and spill into pyrimidine synthesis, producing orotic aciduria with low citrulline and hyperammonemia. It is the most common inherited urea cycle defect and is X-linked.

  33. Question 33Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which enzyme catalyzes the rate-limiting step of heme biosynthesis in hepatocytes?

    1. ALA synthase Correct answer.
    2. Ferrochelatase
    3. Porphobilinogen deaminase
    4. ALA dehydratase

    Explanation

    ALA synthase condenses glycine and succinyl-CoA to form delta-aminolevulinic acid and is the rate-limiting enzyme of heme synthesis. It requires pyridoxal phosphate and is feedback-inhibited by hemin.

  34. Question 34Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    The Glu6Val substitution in the beta-globin chain of sickle hemoglobin is classified as which type of mutation?

    1. Missense Correct answer.
    2. Splice site
    3. Frameshift
    4. Nonsense

    Explanation

    A single base change alters one codon so that valine replaces glutamic acid, which is a missense mutation. The polypeptide length is unchanged, but the altered surface charge allows deoxygenated hemoglobin S to polymerize.

  35. Question 35Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Fluoroquinolones act by inhibiting which bacterial enzyme?

    1. Primase
    2. DNA ligase
    3. DNA gyrase Correct answer.
    4. Helicase

    Explanation

    Fluoroquinolones trap the DNA gyrase (topoisomerase II) and topoisomerase IV complexes, preventing relief of supercoiling and blocking replication. The resulting double-strand breaks are lethal to the bacterium.

  36. Question 36Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    In eukaryotic cells, which RNA polymerase synthesizes messenger RNA precursors?

    1. RNA polymerase II Correct answer.
    2. Reverse transcriptase
    3. RNA polymerase I
    4. RNA polymerase III

    Explanation

    RNA polymerase II transcribes protein-coding genes to produce heterogeneous nuclear RNA, which is processed into mRNA. It is selectively inhibited by alpha-amanitin.

  37. Question 37Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A patient reports no analgesia after standard doses of codeine. Variation in which enzyme most likely explains this failure?

    1. N-acetyltransferase 2
    2. CYP2C9
    3. CYP3A4
    4. CYP2D6 Correct answer.

    Explanation

    Codeine is a prodrug that must be O-demethylated to morphine by CYP2D6. Poor metabolizers form little morphine and obtain poor analgesia, whereas ultrarapid metabolizers risk toxicity.

  38. Question 38Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Adding a competitive inhibitor to an enzyme-catalyzed reaction produces which change in kinetic parameters?

    1. Both Km and Vmax are increased
    2. Km is unchanged but Vmax is reduced
    3. Km increases and Vmax is unchanged Correct answer.
    4. Both Km and Vmax are reduced

    Explanation

    A competitive inhibitor competes with substrate for the active site, so higher substrate concentrations are needed to reach half-maximal velocity. Because the block is surmountable at saturating substrate, Vmax is unchanged while the apparent Km rises.

  39. Question 39Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A drug's volume of distribution is doubled while its systemic clearance remains unchanged. What happens to its elimination half-life?

    1. It is unchanged
    2. It is halved
    3. It is quartered
    4. It is doubled Correct answer.

    Explanation

    Half-life equals 0.693 times volume of distribution divided by clearance, so a twofold rise in Vd with constant clearance doubles the half-life. More extensive tissue distribution means a larger amount must be eliminated to lower the plasma concentration.

  40. Question 40Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A 100 mg intravenous dose produces an AUC of 50 mg·h/L. What is the systemic clearance?

    1. 2 L/h Correct answer.
    2. 1 L/h
    3. 5 L/h
    4. 0.5 L/h

    Explanation

    For intravenous dosing, clearance equals dose divided by total AUC, giving 100 mg / 50 mg·h/L = 2 L/h. Clearance expresses the volume of plasma cleared of drug per unit time.

  41. Question 41Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which dosage form avoids hepatic first-pass metabolism most completely?

    1. Sublingual tablet Correct answer.
    2. Oral solution
    3. Oral tablet
    4. Enteric-coated oral tablet

    Explanation

    Drug absorbed from the sublingual mucosa drains into the superior vena cava, entering the systemic circulation without passing through the portal vein and liver. All swallowed formulations are absorbed into mesenteric veins and therefore face first-pass extraction.

  42. Question 42Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A drug with a half-life of 12 hours is given by constant intravenous infusion. When does the plasma concentration reach approximately steady state?

    1. Approximately 12 hours
    2. Approximately 48 to 60 hours Correct answer.
    3. Approximately 30 minutes
    4. Approximately 5 days

    Explanation

    Steady state is approached after about four to five half-lives regardless of dose rate. With a 12-hour half-life, this corresponds to roughly 48 to 60 hours.

  43. Question 43Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which drug is a potent inducer of CYP3A4 that can lower plasma concentrations of oral contraceptives and many other drugs?

    1. Ketoconazole
    2. Erythromycin
    3. Cimetidine
    4. Rifampin Correct answer.

    Explanation

    Rifampin strongly induces hepatic and intestinal CYP3A4 and P-glycoprotein, accelerating metabolism of coadministered substrates and reducing their efficacy. Enzyme induction develops over days to weeks and resolves slowly after the inducer is stopped.

  44. Question 44Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    A drug has a volume of distribution of 50 L and an oral bioavailability of 1.0. What loading dose gives a target plasma concentration of 2 mg/L?

    1. 200 mg
    2. 100 mg Correct answer.
    3. 25 mg
    4. 50 mg

    Explanation

    Loading dose equals volume of distribution multiplied by target concentration divided by bioavailability: 50 L × 2 mg/L ÷ 1.0 = 100 mg. A loading dose fills the apparent distribution volume rapidly, independent of clearance.

  45. Question 45Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Aminoglycoside antibiotics exert their bactericidal effect by binding to which target?

    1. Penicillin-binding proteins
    2. Bacterial topoisomerase IV
    3. The 30S ribosomal subunit Correct answer.
    4. The 50S peptidyl transferase center

    Explanation

    Aminoglycosides bind the bacterial 30S subunit, distorting the decoding site so that incorrect amino acids are inserted and abnormal proteins are produced. Their action is concentration-dependent and requires oxygen-dependent uptake.

  46. Question 46Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which immunoglobulin class crosses the placenta and provides passive humoral immunity to the fetus and newborn?

    1. IgE
    2. IgM
    3. IgA
    4. IgG Correct answer.

    Explanation

    IgG is actively transported across the placenta via the neonatal Fc receptor, giving the newborn circulating maternal antibody for the first months of life. It is also the predominant immunoglobulin in secondary immune responses.

  47. Question 47Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which complement fragment acts as the principal opsonin that promotes phagocytosis of bacteria?

    1. C9
    2. C5a
    3. C3b Correct answer.
    4. C3a

    Explanation

    C3b covalently binds microbial surfaces and is recognized by complement receptors on phagocytes, greatly enhancing engulfment. This opsonization is a central effector function of the complement system.

  48. Question 48Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which vaccine is contraindicated in a patient receiving high-dose systemic corticosteroids?

    1. Inactivated influenza vaccine
    2. Tetanus toxoid vaccine
    3. Live attenuated MMR vaccine Correct answer.
    4. Recombinant hepatitis B vaccine

    Explanation

    Live attenuated vaccines can replicate and cause disease when cell-mediated immunity is suppressed, so they are withheld in significant immunosuppression. Inactivated, toxoid, and subunit vaccines are safe because they cannot replicate.

  49. Question 49Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which set of conditions describes standard steam sterilization under pressure in an autoclave?

    1. 160 °C dry heat for 2 hours
    2. 60 °C for 60 minutes
    3. 121 °C at 15 psi for 15 minutes Correct answer.
    4. 100 °C at atmospheric pressure for 30 minutes

    Explanation

    Saturated steam at 121 °C (250 °F) under about 15 psi for 15 minutes reliably kills vegetative bacteria and spores by denaturing proteins. Higher pressure raises the steam temperature above the boiling point of water.

  50. Question 50Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

    Which polymer is used as an enteric coating that remains intact in the stomach and dissolves at intestinal pH?

    1. Polyvinylpyrrolidone
    2. Cellulose acetate phthalate Correct answer.
    3. Hydroxypropyl methylcellulose
    4. Magnesium stearate

    Explanation

    Cellulose acetate phthalate carries weakly acidic phthalyl groups that remain unionized and insoluble at gastric pH but ionize and dissolve above about pH 6. Such coatings protect acid-labile drugs and prevent gastric irritation.

  51. Question 51Pharmacology, Medicinal Chemistry, and Toxicology

    Which route of administration places a drug directly into the systemic circulation without an absorption phase?

    1. Oral
    2. Subcutaneous
    3. Intravenous Correct answer.
    4. Intramuscular

    Explanation

    Intravenous administration delivers drug directly into the bloodstream, so absorption and first-pass hepatic metabolism are bypassed. This route produces the most rapid and complete systemic exposure.

  52. Question 52Pharmacology, Medicinal Chemistry, and Toxicology

    The dose of a drug that produces 50% of its maximal effect in a population is called the:

    1. ED50 Correct answer.
    2. Potency
    3. Therapeutic index
    4. LD50

    Explanation

    ED50 is the dose producing 50% of the maximal effect and is a standard measure of drug potency. LD50 refers to lethality, while the therapeutic index is the ratio LD50/ED50.

  53. Question 53Pharmacology, Medicinal Chemistry, and Toxicology

    The bicyclic core of penicillin consists of a beta-lactam ring fused to which ring system?

    1. Imidazolidine ring
    2. Oxazolidine ring
    3. Pyrrolidine ring
    4. Thiazolidine ring Correct answer.

    Explanation

    Penicillins contain a four-membered beta-lactam ring fused to a five-membered thiazolidine ring. Cephalosporins instead have a six-membered dihydrothiazine ring.

  54. Question 54Pharmacology, Medicinal Chemistry, and Toxicology

    Which agent is the specific antidote for acetaminophen (paracetamol) overdose?

    1. Naloxone
    2. Sodium bicarbonate
    3. Flumazenil
    4. Acetylcysteine Correct answer.

    Explanation

    Acetaminophen overdose depletes glutathione, and acetylcysteine replenishes cysteine for glutathione synthesis and helps detoxify the reactive metabolite NAPQI. It is most effective when given early after ingestion.

  55. Question 55Pharmacology, Medicinal Chemistry, and Toxicology

    Stimulation of muscarinic receptors in the heart produces which effect?

    1. Bradycardia Correct answer.
    2. Tachycardia
    3. Vasoconstriction
    4. Increased contractility

    Explanation

    Muscarinic M2 receptors in the sinoatrial node mediate vagal slowing of heart rate. Muscarinic stimulation also increases glandular secretion and smooth muscle contraction.

  56. Question 56Pharmacology, Medicinal Chemistry, and Toxicology

    Which cytochrome P450 isoenzyme metabolizes the largest number of clinically used drugs?

    1. CYP3A4 Correct answer.
    2. CYP2C9
    3. CYP1A2
    4. CYP2D6

    Explanation

    CYP3A4 is responsible for the oxidative metabolism of roughly half of all drugs and is abundant in both the liver and intestinal mucosa. This makes it a major site for drug interactions.

  57. Question 57Pharmacology, Medicinal Chemistry, and Toxicology

    Dimercaprol (BAL) is used to treat poisoning by which agent?

    1. Arsenic Correct answer.
    2. Organophosphate insecticides
    3. Carbon monoxide
    4. Cyanide

    Explanation

    Dimercaprol chelates arsenic, mercury, and other heavy metals through its two sulfhydryl groups. It is not used for organophosphate, cyanide, or carbon monoxide poisoning.

  58. Question 58Pharmacology, Medicinal Chemistry, and Toxicology

    A pharmacologically inactive compound that is converted in the body to an active drug is called a:

    1. Conjugate
    2. Metabolite
    3. Prodrug Correct answer.
    4. Analog

    Explanation

    A prodrug is inactive as administered and requires enzymatic or chemical conversion to release the active species. This strategy can improve absorption, reduce irritation, or alter distribution.

  59. Question 59Pharmacology, Medicinal Chemistry, and Toxicology

    A drug has a half-life of 8 hours and follows first-order elimination. Approximately how long will it take to reach steady state during a continuous infusion?

    1. About 40 hours Correct answer.
    2. About 16 hours
    3. About 8 hours
    4. About 80 hours

    Explanation

    Steady state is reached after approximately four to five half-lives, which is 32 to 40 hours for a drug with an 8-hour half-life. Continuing beyond this produces little additional accumulation.

  60. Question 60Pharmacology, Medicinal Chemistry, and Toxicology

    A drug with a small volume of distribution (Vd) is most likely to be:

    1. Confined largely to plasma Correct answer.
    2. Requiring a large loading dose
    3. Distributed widely into fat
    4. Extensively bound to tissue proteins

    Explanation

    A small volume of distribution indicates that drug remains largely in the vascular compartment rather than distributing into tissues. Loading dose is calculated from Vd, so a small Vd requires a smaller loading dose.

  61. Question 61Pharmacology, Medicinal Chemistry, and Toxicology

    A patient presents with miosis, salivation, bronchorrhea, and muscle fasciculations after pesticide exposure. Which mechanism best explains these findings?

    1. Muscarinic receptor blockade
    2. Adrenergic receptor stimulation
    3. Cholinesterase inhibition Correct answer.
    4. Nicotinic receptor blockade

    Explanation

    Organophosphates inhibit acetylcholinesterase, causing acetylcholine to accumulate at both muscarinic and nicotinic synapses. The muscarinic excess explains salivation and bronchorrhea, while nicotinic excess explains fasciculations.

  62. Question 62Pharmacology, Medicinal Chemistry, and Toxicology

    Methotrexate exerts its anticancer effect by inhibiting which enzyme?

    1. DHFR Correct answer.
    2. Topoisomerase I
    3. Thymidylate synthase
    4. Ribonucleotide reductase

    Explanation

    Methotrexate is a folate analog that inhibits dihydrofolate reductase (DHFR), depleting reduced folates needed for thymidylate and purine synthesis. This blocks DNA synthesis in rapidly dividing cells.

  63. Question 63Pharmacology, Medicinal Chemistry, and Toxicology

    Which change would most likely increase the oral bioavailability of a drug that undergoes extensive first-pass metabolism?

    1. High-fat meal
    2. P-glycoprotein induction
    3. CYP3A4 inhibition Correct answer.
    4. Larger particle size

    Explanation

    First-pass metabolism occurs in the gut wall and liver, so inhibiting CYP3A4 increases the fraction of drug reaching systemic circulation. P-glycoprotein induction would decrease bioavailability by increasing efflux.

  64. Question 64Pharmacology, Medicinal Chemistry, and Toxicology

    Which finding is most characteristic of acetaminophen-induced hepatic injury?

    1. Hypoglycemia with hyperkalemia
    2. Rising INR Correct answer.
    3. Elevated amylase with lipase
    4. Anion gap acidosis with normal liver tests

    Explanation

    Acetaminophen toxicity causes centrilobular hepatic necrosis, reflected by rising aminotransferases and coagulopathy with an elevated INR. Early recognition and acetylcysteine are critical.

  65. Question 65Pharmacology, Medicinal Chemistry, and Toxicology

    A patient develops severe bronchospasm after receiving a nonselective beta-blocker. Which drug is most appropriate to reverse the beta-2 blockade?

    1. Albuterol Correct answer.
    2. Atropine
    3. Phentolamine
    4. Propranolol

    Explanation

    Albuterol is a selective beta-2 agonist that relaxes bronchial smooth muscle and reverses bronchospasm. Atropine and phentolamine do not reverse beta-2 blockade.

  66. Question 66Pharmacology, Medicinal Chemistry, and Toxicology

    Which structural feature of captopril allows it to coordinate the zinc ion in the active site of angiotensin-converting enzyme?

    1. Sulfhydryl group Correct answer.
    2. Guanidinium group
    3. Hydroxyl group
    4. Carboxylate group

    Explanation

    Captopril contains a sulfhydryl group that coordinates the zinc ion in the ACE active site. This interaction underlies its potent inhibition of angiotensin conversion.

  67. Question 67Pharmacology, Medicinal Chemistry, and Toxicology

    Aminoglycosides require which condition for optimal bactericidal activity?

    1. An anaerobic environment
    2. A high-protein environment
    3. An aerobic environment Correct answer.
    4. An acidic environment

    Explanation

    Aminoglycosides are taken up into bacteria by an oxygen-dependent active transport process, so they are less effective against anaerobes. Their activity is also reduced in acidic and anaerobic environments.

  68. Question 68Pharmacology, Medicinal Chemistry, and Toxicology

    Ultrarapid CYP2D6 metabolizers are at increased risk of opioid toxicity from which drug?

    1. Morphine
    2. Codeine Correct answer.
    3. Hydromorphone
    4. Fentanyl

    Explanation

    Codeine is a prodrug converted by CYP2D6 to morphine. Ultrarapid metabolizers produce more morphine and are at risk of opioid toxicity.

  69. Question 69Pharmacology, Medicinal Chemistry, and Toxicology

    Which drug is given with atropine as a first-line antidote for acute organophosphate poisoning?

    1. Benztropine
    2. Neostigmine
    3. Pralidoxime Correct answer.
    4. Physostigmine

    Explanation

    Pralidoxime reactivates acetylcholinesterase by removing the phosphate group from the enzyme before aging occurs. It is given with atropine, which antagonizes muscarinic effects.

  70. Question 70Pharmacology, Medicinal Chemistry, and Toxicology

    A drug follows zero-order elimination. What happens to plasma concentration when the infusion rate exceeds the elimination capacity?

    1. Prompt plateau
    2. Oscillation around a mean
    3. Unbounded accumulation Correct answer.
    4. Exponential decline

    Explanation

    In zero-order elimination, a constant amount of drug is removed per unit time regardless of concentration. If infusion exceeds that capacity, drug accumulates without reaching a plateau.

  71. Question 71Pharmacology, Medicinal Chemistry, and Toxicology

    5-Fluorouracil is converted to which metabolite that inhibits thymidylate synthase?

    1. FdUMP Correct answer.
    2. FUTP
    3. FUDP
    4. FdUDP

    Explanation

    5-Fluorouracil is converted to FdUMP, which forms a ternary complex with thymidylate synthase and folate, blocking thymidine synthesis. FUTP can be incorporated into RNA but does not inhibit thymidylate synthase.

  72. Question 72Pharmacology, Medicinal Chemistry, and Toxicology

    Which finding best distinguishes early salicylate toxicity from early ethylene glycol toxicity?

    1. Tinnitus
    2. Oxalate crystals in urine
    3. Respiratory alkalosis Correct answer.
    4. Hyperkalemia

    Explanation

    Salicylate toxicity often produces early respiratory alkalosis due to direct medullary stimulation, whereas ethylene glycol causes an early metabolic acidosis with oxalate crystals. Tinnitus is a salicylate effect but does not distinguish the two.

  73. Question 73Pharmacology, Medicinal Chemistry, and Toxicology

    A partial agonist produces a lower maximal response than a full agonist. What effect does it have when added in the presence of a full agonist?

    1. It has no effect
    2. It irreversibly blocks the receptor
    3. It increases the maximal response
    4. It acts as a competitive antagonist Correct answer.

    Explanation

    A partial agonist occupies the same receptor but cannot produce the full response; when a full agonist is present, it competes and lowers the maximal response. This is competitive partial antagonism.

  74. Question 74Pharmacology, Medicinal Chemistry, and Toxicology

    Clavulanic acid is combined with amoxicillin primarily because clavulanic acid produces which effect?

    1. Prodrug activation
    2. Beta-lactamase inhibition Correct answer.
    3. Protein synthesis inhibition
    4. Increased renal clearance

    Explanation

    Clavulanic acid binds irreversibly to beta-lactamase, protecting amoxicillin from enzymatic hydrolysis. It has little antibacterial activity on its own.

  75. Question 75Pharmacology, Medicinal Chemistry, and Toxicology

    A patient stabilized on warfarin is started on rifampin. Which mechanism best explains the reduced anticoagulant effect?

    1. CYP enzyme induction Correct answer.
    2. Decreased platelet aggregation
    3. Vitamin K epoxide reductase inhibition
    4. Albumin displacement

    Explanation

    Rifampin is a potent inducer of hepatic CYP enzymes, increasing warfarin metabolism and lowering its anticoagulant effect. Displacement from albumin would transiently increase free warfarin rather than reduce its effect.

  76. Question 76Pharmacology, Medicinal Chemistry, and Toxicology

    Which of the following drug biotransformation reactions is classified as a phase II (conjugation) reaction?

    1. Glucuronidation of a phenol Correct answer.
    2. Hydrolysis of an ester by esterases
    3. Oxidation by a cytochrome P450 enzyme
    4. Reduction of an aromatic nitro group

    Explanation

    Phase II reactions conjugate a functional group with an endogenous moiety such as glucuronic acid, sulfate, acetate, or glutathione, generally producing a more water-soluble, more easily excreted product. Oxidation, reduction, and hydrolysis are phase I (functionalization) reactions that introduce or unmask a reactive group. Glucuronidation is the most common phase II pathway in humans.

  77. Question 77Pharmacology, Medicinal Chemistry, and Toxicology

    How does a competitive antagonist affect an agonist dose-response curve?

    1. It shifts the curve to the right with a reduced maximal response
    2. It shifts the curve downward with no change in EC50
    3. It shifts the curve to the left with an increased potency
    4. It shifts the curve to the right with an unchanged maximal response Correct answer.

    Explanation

    A competitive antagonist binds reversibly at the agonist site, so increasing the agonist concentration can overcome the blockade. This produces a parallel rightward shift in the dose-response curve with an unchanged maximal efficacy, only requiring a higher agonist concentration (higher EC50).

  78. Question 78Pharmacology, Medicinal Chemistry, and Toxicology

    Which agent is used as the specific antidote in acetaminophen overdose?

    1. Acetylcysteine Correct answer.
    2. Flumazenil
    3. Deferoxamine
    4. Physostigmine salicylate

    Explanation

    Acetylcysteine restores hepatic glutathione stores and directly conjugates the reactive metabolite N-acetyl-p-benzoquinone imine, so it detoxifies the offending species. It is most effective when started within about 8 to 10 hours of ingestion. Other listed drugs reverse unrelated poisonings.

  79. Question 79Pharmacology, Medicinal Chemistry, and Toxicology

    The therapeutic index of a drug is best defined as which of the following?

    1. The plasma concentration producing half-maximal effect
    2. The fraction of drug bound to plasma albumin
    3. The ratio of clearance to volume of distribution
    4. LD50 divided by ED50 Correct answer.

    Explanation

    The therapeutic index compares the dose producing toxicity in 50% of subjects with the dose producing the desired effect in 50% of subjects. A larger ratio indicates a wider margin of safety between effective and toxic exposures. Drugs with narrow indices, such as digoxin, lithium, and warfarin, require monitoring.

  80. Question 80Pharmacology, Medicinal Chemistry, and Toxicology

    Drug B displaces drug A from plasma albumin binding sites. Which immediate consequence is expected for drug A?

    1. A transient rise in free fraction Correct answer.
    2. A reduced pharmacologic effect at the receptor
    3. An immediate increase in total plasma concentration
    4. A fall in its volume of distribution

    Explanation

    Displacement shifts drug A from bound to unbound form, transiently raising free concentration and therefore effect and toxicity risk. With time, increased clearance and redistribution restore a new steady state in which free concentration is largely unchanged but total concentration is lower. The transient free-drug surge explains the clinical concern.

  81. Question 81Pharmacology, Medicinal Chemistry, and Toxicology

    Grapefruit juice inhibits intestinal CYP3A4. For an orally administered drug that is a CYP3A4 substrate, which change is most likely?

    1. Increased oral bioavailability Correct answer.
    2. Reduced renal tubular secretion
    3. Delayed gastric emptying with reduced absorption
    4. Induction of hepatic glucuronidation

    Explanation

    Inhibiting intestinal CYP3A4 reduces presystemic metabolism in enterocytes, so a larger fraction of the dose reaches the portal circulation intact. Oral bioavailability rises and plasma concentrations may become toxic. Intravenous dosing bypasses this intestinal first-pass effect, so it is unaffected.

  82. Question 82Pharmacology, Medicinal Chemistry, and Toxicology

    A weak acid drug with a pKa of 4.4 is present in urine at pH 7.4. Which statement describes its ionization and renal handling?

    1. Mostly nonionized, so it is poorly reabsorbed
    2. Mostly ionized, so it is poorly reabsorbed Correct answer.
    3. Mostly ionized, so it is readily reabsorbed
    4. Mostly nonionized, so it is readily reabsorbed

    Explanation

    When urinary pH is well above the pKa of a weak acid, the equilibrium favors the deprotonated, ionized form. Ionized species are lipid-insoluble and cannot readily cross the tubular membrane, so they remain in urine and are excreted. Alkalinizing urine therefore accelerates elimination of weak acids such as salicylates.

  83. Question 83Pharmacology, Medicinal Chemistry, and Toxicology

    Which chelating agent is indicated for acute iron overdose?

    1. Succimer (DMSA)
    2. Penicillamine
    3. Deferoxamine Correct answer.
    4. Prussian blue

    Explanation

    Deferoxamine is a hexadentate siderophore that binds ferric iron to form ferrioxamine, which is excreted in urine. It is the classic parenteral chelator for severe iron poisoning and is also used in thalassemia iron overload. The other agents chelate different metals or enhance fecal elimination of other toxins.

  84. Question 84Pharmacology, Medicinal Chemistry, and Toxicology

    A drug has a volume of distribution of 50 L. What loading dose is required to achieve an initial plasma concentration of 2 mg/L?

    1. 25 mg
    2. 100 mg Correct answer.
    3. 200 mg
    4. 50 mg

    Explanation

    Loading dose equals the target concentration multiplied by the volume of distribution: 2 mg/L times 50 L equals 100 mg. The calculation assumes rapid distribution and negligible elimination before the concentration is achieved. Clearance determines the maintenance dose, not the loading dose.

  85. Question 85Pharmacology, Medicinal Chemistry, and Toxicology

    A patient taking a monoamine oxidase inhibitor eats aged cheese rich in tyramine. Which reaction is most likely?

    1. Serotonin syndrome from increased synaptic serotonin release
    2. Hypertensive crisis from norepinephrine release Correct answer.
    3. Anticholinergic delirium from muscarinic blockade
    4. Hypotension from alpha-adrenergic blockade

    Explanation

    Tyramine is an indirect sympathomimetic that normally undergoes extensive first-pass metabolism by monoamine oxidase in the gut and liver. When that enzyme is inhibited, tyramine reaches adrenergic nerve terminals and displaces stored norepinephrine, causing a surge in blood pressure. This is the classic cheese reaction.

  86. Question 86Pharmacology, Medicinal Chemistry, and Toxicology

    Beta-lactam antibiotics exert their bactericidal effect by which mechanism?

    1. Inhibiting bacterial DNA gyrase
    2. Blocking peptide bond formation at the 30S ribosomal subunit
    3. Preventing peptidoglycan cross-linking Correct answer.
    4. Disrupting the cytoplasmic membrane

    Explanation

    Beta-lactams acylate the transpeptidase enzymes (penicillin-binding proteins) that cross-link peptidoglycan strands in the bacterial cell wall. Loss of cross-linking weakens the wall so that the cell lyses under osmotic pressure, which requires actively dividing organisms. This is why resistance often involves beta-lactamase enzymes or altered penicillin-binding proteins.

  87. Question 87Pharmacology, Medicinal Chemistry, and Toxicology

    A patient with glucose-6-phosphate dehydrogenase deficiency is at highest risk of hemolytic anemia from which drug?

    1. Primaquine Correct answer.
    2. Omeprazole
    3. Amoxicillin
    4. Atorvastatin

    Explanation

    Primaquine is an 8-aminoquinoline that generates oxidative stress in erythrocytes. In G6PD deficiency, NADPH production is insufficient to regenerate reduced glutathione, so oxidative hemolysis occurs. Other classic offenders include dapsone, nitrofurantoin, and high-dose aspirin.

  88. Question 88Pharmacology, Medicinal Chemistry, and Toxicology

    A drug follows capacity-limited (Michaelis-Menten) kinetics. If the dose is increased slightly while concentrations are already near the Km, what happens to the steady-state concentration?

    1. It rises by the same proportion as the dose
    2. It stays constant until the enzyme is fully saturated
    3. It rises by a smaller proportion than the dose
    4. It rises disproportionately more Correct answer.

    Explanation

    Near Km, a small rise in dose produces a large fractional increase in metabolizing enzyme saturation, so clearance falls and steady-state concentration climbs more than proportionally. Small dose adjustments can therefore cause unexpectedly large concentration changes and toxicity, as seen with phenytoin. Only well below Km does the drug behave in a first-order, proportional manner.

  89. Question 89Pharmacology, Medicinal Chemistry, and Toxicology

    Most drugs that delay cardiac repolarization and precipitate torsades de pointes share which molecular action?

    1. Inhibition of the sodium-potassium ATPase
    2. Blockade of voltage-gated sodium channels
    3. Blockade of the hERG potassium current Correct answer.
    4. Activation of L-type calcium channels

    Explanation

    The rapid delayed rectifier potassium current (IKr), carried by hERG channels, is the most common off-target of QT-prolonging drugs. Blocking it lengthens the action potential and QT interval, creating the substrate for early afterdepolarizations and polymorphic ventricular tachycardia. This promiscuous liability is amplified by hypokalemia, hypomagnesemia, and concurrent QT-prolonging agents.

  90. Question 90Pharmacology, Medicinal Chemistry, and Toxicology

    Warfarin is administered as a racemate. Which cytochrome P450 isoform primarily metabolizes the more pharmacologically potent S-enantiomer?

    1. CYP1A2
    2. CYP2C9 Correct answer.
    3. CYP2E1
    4. CYP2D6

    Explanation

    S-warfarin is roughly three to five times more potent as a vitamin K epoxide reductase inhibitor than R-warfarin and is cleared mainly by CYP2C9. Consequently, CYP2C9 inhibitors such as amiodarone and fluconazole raise INR, and CYP2C9 loss-of-function variants increase bleeding risk. The R-enantiomer is handled largely by CYP1A2 and CYP3A4.

  91. Question 91Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which laboratory test is used to monitor the anticoagulant effect of warfarin therapy?

    1. Prothrombin time with INR Correct answer.
    2. Bleeding time
    3. Activated partial thromboplastin time
    4. Thrombin time

    Explanation

    Warfarin inhibits synthesis of vitamin K-dependent clotting factors, which prolongs the prothrombin time; the result is standardized as the INR so values are comparable across laboratories. The INR is therefore the standard monitoring parameter for warfarin dose adjustment.

  92. Question 92Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    How should levothyroxine be timed relative to meals to maximize absorption?

    1. With calcium and iron supplements at bedtime
    2. Immediately after a high-fiber breakfast
    3. With the largest meal of the day
    4. Empty stomach, 30-60 min before breakfast Correct answer.

    Explanation

    Levothyroxine absorption is reduced by food, dietary fiber, calcium, and iron, so it is taken on an empty stomach and separated from those substances. Administering the dose 30 to 60 minutes before breakfast gives consistent absorption and stable TSH.

  93. Question 93Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which adverse effect is most characteristic of ACE inhibitor therapy and results from accumulation of bradykinin?

    1. Reflex tachycardia
    2. Hypokalemia
    3. Peripheral edema
    4. Dry, persistent cough Correct answer.

    Explanation

    ACE inhibitors block the kinase that degrades bradykinin, and the resulting bradykinin accumulation irritates the airway and produces a dry, tickling cough. The cough typically resolves within days to weeks after the drug is discontinued or switched to an angiotensin receptor blocker.

  94. Question 94Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    In which situation should metformin be avoided because of the risk of lactic acidosis?

    1. Well-controlled hypothyroidism
    2. Mild hepatic steatosis with normal liver enzymes
    3. eGFR below 30 mL/min/1.73 m2 Correct answer.
    4. Stable angina

    Explanation

    Metformin is cleared renally and accumulates when kidney function is severely reduced, increasing the risk of lactic acidosis; it is contraindicated below an eGFR of 30 mL/min/1.73 m2. It is also held during acute illness, hypoxia, and iodinated contrast procedures.

  95. Question 95Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which agent is the specific antidote for opioid-induced respiratory depression?

    1. Flumazenil
    2. Physostigmine
    3. N-acetylcysteine
    4. Naloxone Correct answer.

    Explanation

    Naloxone is a competitive opioid receptor antagonist that rapidly reverses opioid-induced respiratory depression and sedation. Because its duration is shorter than that of many opioids, patients must be monitored for recurrent depression.

  96. Question 96Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    In a patient with asthma, which inhaled medication is appropriate for rapid relief of acute bronchospasm?

    1. Albuterol Correct answer.
    2. Montelukast
    3. Fluticasone propionate
    4. Tiotropium

    Explanation

    Short-acting beta-2 agonists such as albuterol relax airway smooth muscle within minutes and are the drugs of choice for acute symptom relief. Inhaled corticosteroids, leukotriene modifiers, and long-acting anticholinergics provide controller or maintenance effects and do not relieve acute bronchospasm.

  97. Question 97Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which laboratory parameter should be obtained at baseline, and when muscle symptoms occur, in a patient starting a statin?

    1. Serum amylase
    2. Serum uric acid
    3. Serum potassium
    4. Creatine kinase Correct answer.

    Explanation

    Statin-associated muscle symptoms range from myalgia to rhabdomyolysis, which releases creatine kinase into plasma. A baseline CK value helps interpretation if muscle symptoms later develop and supports decisions about stopping or switching therapy.

  98. Question 98Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which of these drugs is most commonly associated with QT-interval prolongation?

    1. Metformin
    2. Lisinopril
    3. Ondansetron Correct answer.
    4. Amoxicillin

    Explanation

    Ondansetron blocks the delayed rectifier potassium current and can prolong the QT interval in a dose-dependent manner, particularly in patients with electrolyte abnormalities or other QT-prolonging drugs. Serious risk rises in patients with hypokalemia, hypomagnesemia, or underlying conduction disease.

  99. Question 99Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A 70-year-old man with MRSA bacteremia is receiving intravenous vancomycin. Which monitoring strategy best reflects current guidance for balancing efficacy and nephrotoxicity risk?

    1. Trough levels measured only once, at the end of therapy
    2. AUC-guided dosing with serum creatinine monitoring Correct answer.
    3. Peak level drawn 30 minutes after each dose to confirm adequacy
    4. Random serum levels drawn at any time of day

    Explanation

    Current consensus guidance recommends targeting an AUC24/MIC of 400 to 600 for serious MRSA infections, with serum creatinine followed to detect nephrotoxicity. AUC-guided dosing is both more effective and less nephrotoxic than targeting troughs alone.

  100. Question 100Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient taking lithium carbonate for bipolar disorder presents with coarse tremor, vomiting, and confusion. Which finding best supports lithium toxicity?

    1. Lithium 0.6 mEq/L drawn 12 hours after a dose
    2. Lithium 0.4 mEq/L with normal renal function
    3. Lithium 2.1 mEq/L with rising creatinine Correct answer.
    4. Lithium 0.8 mEq/L drawn 2 hours after a dose

    Explanation

    Maintenance lithium concentrations usually fall between 0.6 and 1.2 mEq/L; values above 1.5 mEq/L are associated with toxicity and levels above 2 mEq/L with severe symptoms. A level of 2.1 mEq/L accompanied by worsening renal function is a medical emergency requiring hemodialysis consideration.

  101. Question 101Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which drug combination places a patient at highest risk for serotonin syndrome?

    1. Warfarin plus levothyroxine
    2. Tramadol plus sertraline Correct answer.
    3. Amlodipine plus atorvastatin
    4. Omeprazole plus metformin

    Explanation

    Serotonin syndrome results from excessive serotonergic activity, and combining two serotonergic agents such as tramadol and an SSRI markedly increases risk. The classic triad is altered mental status, autonomic instability, and neuromuscular hyperactivity such as clonus.

  102. Question 102Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient whose INR has been stable on warfarin is started on trimethoprim-sulfamethoxazole for a urinary tract infection. What is the most appropriate management?

    1. Check INR in 3 to 5 days and adjust the warfarin dose Correct answer.
    2. Discontinue warfarin until the antibiotic course is completed
    3. Double the warfarin dose empirically for the duration of therapy
    4. No change is needed because antibiotics do not affect the INR

    Explanation

    Trimethoprim-sulfamethoxazole inhibits CYP2C9 and displaces warfarin from albumin, so the INR often rises within several days and bleeding risk increases. Close INR monitoring with preemptive dose reduction is the standard approach; a safer antibiotic is preferred when possible.

  103. Question 103Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which regimen represents guideline-directed medical therapy for a patient with heart failure with reduced ejection fraction who has no contraindications?

    1. Sacubitril/valsartan, carvedilol, spironolactone, dapagliflozin Correct answer.
    2. Losartan, amiodarone, rivaroxaban, and insulin
    3. Verapamil, hydralazine, isosorbide dinitrate, and atorvastatin
    4. Amlodipine, furosemide, digoxin, and warfarin

    Explanation

    The four pillars of therapy for heart failure with reduced ejection fraction are a renin-angiotensin system inhibitor, a beta-blocker, a mineralocorticoid receptor antagonist, and an SGLT2 inhibitor. Each class reduces mortality and hospitalizations and should be titrated toward target doses.

  104. Question 104Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with mild persistent asthma uses a low-dose inhaled corticosteroid but reports symptoms more than twice weekly. What is the preferred next step?

    1. Start daily oral prednisone
    2. Switch to a leukotriene receptor antagonist as monotherapy only
    3. Add a long-acting beta-2 agonist or increase to medium-dose inhaled corticosteroid Correct answer.
    4. Stop the inhaled corticosteroid and use a long-acting beta-2 agonist alone

    Explanation

    When symptoms persist on low-dose inhaled corticosteroid, guidelines recommend stepping up by adding a long-acting beta-2 agonist or increasing the inhaled corticosteroid dose. Inhaled corticosteroids must never be stopped in favor of long-acting beta-2 agonist monotherapy in asthma because of the risk of severe exacerbations.

  105. Question 105Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient taking phenytoin develops nystagmus and ataxia after a modest dose increase. Which principle best explains this finding?

    1. Phenytoin is cleared unchanged by the kidney
    2. Phenytoin is not bound to plasma proteins
    3. Phenytoin follows linear first-order elimination at therapeutic doses
    4. Saturable metabolism causes disproportionate level rises Correct answer.

    Explanation

    Phenytoin undergoes Michaelis-Menten (capacity-limited) metabolism, so the enzymes become saturated within the therapeutic range. Small dose increases can then produce large, nonlinear rises in serum concentration and toxicity; dose changes should therefore be small and guided by levels.

  106. Question 106Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which parameter is most useful for adjusting the dose of a renally cleared drug?

    1. Body mass index
    2. Estimated creatinine clearance Correct answer.
    3. Serum bilirubin concentration
    4. Serum albumin

    Explanation

    Most renal dosing recommendations in product labeling are based on creatinine clearance estimated with the Cockcroft-Gault equation, which incorporates age, weight, sex, and serum creatinine. eGFR from the CKD-EPI equation is not interchangeable with these values for dose adjustment.

  107. Question 107Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with acute coronary syndrome and a newly placed coronary stent is a known CYP2C19 poor metabolizer. Which antiplatelet agent is preferred over clopidogrel?

    1. Ticagrelor Correct answer.
    2. Aspirin at a higher maintenance dose
    3. Dipyridamole
    4. Warfarin

    Explanation

    Clopidogrel is a prodrug requiring CYP2C19 activation, so poor metabolizers have reduced antiplatelet effect and higher stent thrombosis risk. Ticagrelor and prasugrel do not depend on CYP2C19 activation and are preferred in these patients.

  108. Question 108Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which monitoring approach best balances efficacy and toxicity when gentamicin is given as an extended-interval dose?

    1. A level drawn 6 to 14 hours post-dose read with a nomogram Correct answer.
    2. Peak level drawn 30 minutes after each dose to confirm adequacy
    3. Random level drawn at any point in the dosing interval
    4. Trough level drawn immediately after the infusion ends

    Explanation

    Extended-interval aminoglycoside dosing aims for a high peak and a long drug-free period; a single concentration drawn 6 to 14 hours after the dose, interpreted with a validated nomogram, estimates both peak and trough exposure. Renal function and ototoxicity symptoms are monitored concurrently.

  109. Question 109Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A pharmacist needs the most current primary evidence on a newly approved drug. Which source qualifies as primary literature?

    1. The manufacturer's package insert
    2. An original randomized controlled trial report Correct answer.
    3. A review article in a continuing education journal
    4. A tertiary database such as Lexicomp

    Explanation

    Primary literature consists of original research reports in which investigators generate and analyze new data, such as randomized controlled trials and cohort studies. Secondary and tertiary sources summarize or interpret that primary evidence and may lag behind it.

  110. Question 110Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which finding most increases a patient's risk of digoxin toxicity?

    1. Hypernatremia
    2. Hypokalemia Correct answer.
    3. Elevated serum albumin
    4. Hyperkalemia

    Explanation

    Digoxin binds the sodium-potassium ATPase, and low extracellular potassium enhances drug binding and toxicity at any given digoxin concentration. Hypokalemia from loop or thiazide diuretics is therefore a major precipitant of arrhythmias in digoxin-treated patients.

  111. Question 111Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Before starting abacavir, which screening test is required to reduce the risk of a severe hypersensitivity reaction?

    1. HLA-B*1502
    2. HLA-B*5701 Correct answer.
    3. Thiopurine methyltransferase activity
    4. Glucose-6-phosphate dehydrogenase activity

    Explanation

    Abacavir hypersensitivity is strongly associated with the HLA-B*5701 allele, and screening before initiation markedly reduces the incidence of this potentially fatal reaction. Patients who carry the allele should not receive abacavir.

  112. Question 112Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient given unfractionated heparin for 6 days has a platelet count that falls from 250,000 to 80,000/mcL and develops a new arterial thrombosis. What is the most appropriate action?

    1. Continue heparin and recheck platelets in one week
    2. Stop heparin and transfuse platelets
    3. Switch to low-molecular-weight heparin and continue
    4. Stop heparin and start argatroban Correct answer.

    Explanation

    This presentation is consistent with heparin-induced thrombocytopenia, an immune-mediated reaction that paradoxically causes thrombosis rather than bleeding. Heparin must be stopped immediately and a non-heparin anticoagulant such as argatroban, bivalirudin, or fondaparinux started.

  113. Question 113Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which prophylactic measure best prevents tumor lysis syndrome in a high-risk patient beginning cytotoxic chemotherapy?

    1. Fluid restriction with potassium supplementation
    2. Prophylactic platelet transfusion before each cycle
    3. A low-purine diet as the only intervention
    4. Vigorous hydration plus allopurinol or rasburicase Correct answer.

    Explanation

    Tumor lysis syndrome prophylaxis relies on high-volume intravenous hydration to maintain urine output plus a hypouricemic agent: allopurinol to block uric acid formation or rasburicase to degrade existing uric acid. Potassium and phosphate are monitored closely and supplementation is avoided unless clearly indicated.

  114. Question 114Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A suspected adverse drug reaction scores 7 on the Naranjo probability scale. How should the reaction be classified?

    1. Possible
    2. Doubtful
    3. Unlikely
    4. Probable Correct answer.

    Explanation

    On the Naranjo scale, a score of 9 or more is definite, 5 to 8 is probable, 1 to 4 is possible, and 0 or less is doubtful. A score of 7 therefore falls in the probable category and usually warrants reporting and documentation.

  115. Question 115Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which statement about the management of Stevens-Johnson syndrome and toxic epidermal necrolysis is most accurate?

    1. Systemic corticosteroids are proven to reduce mortality in randomized trials
    2. Prophylactic broad-spectrum antibiotics are routinely recommended
    3. The culprit drug may be continued if the initial rash appears mild
    4. Immediate withdrawal of the suspected drug is the most important step Correct answer.

    Explanation

    Early identification and prompt discontinuation of the culprit drug is the single most important intervention and is associated with improved survival. Supportive care in a burn-like unit, fluid and electrolyte management, and wound care are the mainstays of treatment.

  116. Question 116Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient presents to the emergency department 6 hours after ingesting a large quantity of acetaminophen. Which antidote is indicated?

    1. Acetylcysteine Correct answer.
    2. Flumazenil
    3. Naloxone
    4. Deferoxamine

    Explanation

    Acetaminophen is metabolized by CYP2E1 to the reactive intermediate NAPQI, which depletes hepatic glutathione and causes centrilobular necrosis. Acetylcysteine restores glutathione stores and also serves as a direct sulfhydryl donor, and it is most effective when given early after ingestion. It remains indicated for patients with a toxic ingestion even when the interval exceeds 8 hours.

  117. Question 117Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient has been taking amiodarone for 2 years. Which laboratory test should be monitored periodically because of a characteristic adverse effect of this drug?

    1. Serum lipase
    2. Serum uric acid
    3. Serum creatine kinase
    4. Thyroid-stimulating hormone Correct answer.

    Explanation

    Amiodarone is an iodine-rich compound that can cause both hypothyroidism and thyrotoxicosis, so thyroid function must be checked at baseline and at least every 6 months. Pulmonary, hepatic, ocular, and neurologic toxicity also warrant surveillance. Uric acid and creatine kinase are not part of routine amiodarone monitoring.

  118. Question 118Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A 60-year-old with type 2 diabetes has an estimated glomerular filtration rate of 25 mL/min/1.73 m2. Which action regarding metformin is most appropriate?

    1. Add a sulfonylurea and continue metformin
    2. Reduce the dose by half and monitor
    3. Continue the current dose unchanged
    4. Discontinue metformin Correct answer.

    Explanation

    Metformin is contraindicated when the eGFR falls below 30 mL/min/1.73 m2 because reduced clearance increases the risk of lactic acidosis. Between 30 and 45 mL/min/1.73 m2 the drug may be continued at a reduced dose only if the patient is stable. Dose reduction is not an adequate safeguard once the eGFR drops below 30.

  119. Question 119Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient uses a fluticasone inhaler twice daily. Which counseling point best reduces the risk of oral candidiasis?

    1. Use the inhaler immediately before meals
    2. Increase the dose when symptoms worsen
    3. Rinse the mouth and spit after each use Correct answer.
    4. Hold the breath for 30 seconds after inhaling

    Explanation

    Inhaled corticosteroids deposit drug in the oropharynx, where local immunosuppression promotes Candida overgrowth and dysphonia. Rinsing the mouth and spitting after each dose removes residual drug. A spacer further reduces oropharyngeal deposition.

  120. Question 120Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which serious adverse effect is the basis of the boxed warning for metoclopramide?

    1. Tardive dyskinesia Correct answer.
    2. Ototoxicity
    3. Nephrotoxicity
    4. Aplastic anemia

    Explanation

    Metoclopramide is a dopamine D2 antagonist, and sustained blockade in the nigrostriatal pathway can produce tardive dyskinesia that is often irreversible. Risk rises with duration of use and with age, so therapy is generally limited to 12 weeks. Patients should be counseled to report involuntary movements immediately.

  121. Question 121Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which supplement is routinely added to low-dose weekly methotrexate therapy to reduce mucosal and gastrointestinal toxicity?

    1. Folic acid Correct answer.
    2. Vitamin D
    3. Vitamin K
    4. Vitamin B12

    Explanation

    Methotrexate inhibits dihydrofolate reductase, depleting reduced folates in rapidly dividing tissues and causing stomatitis, nausea, and marrow suppression. Supplementing folic acid (typically 1 mg daily) reduces these effects without meaningfully reducing the anti-inflammatory response. The weekly dosing interval itself must never be confused with daily dosing.

  122. Question 122Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    An otherwise healthy woman with acute uncomplicated cystitis and normal renal function requires oral therapy. Which agent is the preferred first-line choice?

    1. Ciprofloxacin
    2. Nitrofurantoin Correct answer.
    3. Amoxicillin
    4. Azithromycin

    Explanation

    Nitrofurantoin achieves high bladder concentrations and is recommended as a first-line 5-day regimen for uncomplicated cystitis. Fluoroquinolones are reserved for more serious infections because of collateral damage and resistance concerns. Amoxicillin is avoided empirically because of high rates of E. coli resistance.

  123. Question 123Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which instruction is correct for a patient beginning levothyroxine replacement?

    1. Take the dose every other day to avoid accumulation
    2. Take each dose at bedtime with calcium carbonate
    3. Take each dose on an empty stomach 30 to 60 minutes before breakfast Correct answer.
    4. Take each dose with breakfast to improve absorption

    Explanation

    Levothyroxine absorption is impaired by food, calcium, iron, and proton pump inhibitors, so it is taken on an empty stomach with water and the patient waits 30 to 60 minutes before eating. Consistent timing supports stable thyroid-stimulating hormone values. A daily dosing interval is standard because of the drug's long half-life.

  124. Question 124Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient whose INR has been stable on warfarin for a year is started on amiodarone. Which management step is most appropriate?

    1. Replace warfarin with enoxaparin for the duration of amiodarone therapy
    2. Check the INR more often and expect to lower the warfarin dose Correct answer.
    3. Increase the warfarin dose empirically by 25%
    4. Continue the current warfarin dose and recheck the INR in 3 months

    Explanation

    Amiodarone inhibits CYP2C9 and CYP3A4 and reduces warfarin clearance, typically raising the INR by 1 to 2 units over several weeks. Because amiodarone has a very long half-life, the interaction can persist for months after discontinuation. Frequent INR checks with anticipatory dose reduction prevent bleeding.

  125. Question 125Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient started on lisinopril 3 weeks ago reports a persistent dry, tickling cough. There is no dyspnea, wheeze, or peripheral edema. Which action is most appropriate?

    1. Switch to losartan Correct answer.
    2. Stop all antihypertensive therapy
    3. Double the lisinopril dose
    4. Add an inhaled corticosteroid

    Explanation

    ACE inhibitor cough results from bradykinin and substance P accumulation when the kininase II pathway is blocked. It is not dose-dependent and does not respond to added respiratory therapy. Switching to an angiotensin receptor blocker preserves renin-angiotensin blockade while avoiding bradykinin accumulation.

  126. Question 126Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which monitoring test is mandatory for a patient beginning clozapine?

    1. Annual electroencephalogram
    2. Weekly serum creatinine
    3. Regular absolute neutrophil count Correct answer.
    4. Monthly serum lipase

    Explanation

    Clozapine carries a boxed warning for severe neutropenia and agranulocytosis, so the absolute neutrophil count must be checked before initiation and at intervals defined by the risk evaluation program. Clozapine also requires monitoring for myocarditis, metabolic effects, and seizures. Treatment is interrupted if the neutrophil count falls below defined thresholds.

  127. Question 127Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which regimen is recommended for an initial episode of mild-to-moderate Clostridioides difficile infection in an adult?

    1. Oral metronidazole for 14 days
    2. Intravenous vancomycin
    3. Loperamide to reduce diarrhea
    4. Oral vancomycin or fidaxomicin Correct answer.

    Explanation

    Oral vancomycin and fidaxomicin are preferred for initial C. difficile infection because they achieve high colonic concentrations and outperform metronidazole. Metronidazole is now reserved for situations in which preferred agents are unavailable. Antimotility drugs risk precipitating toxic megacolon.

  128. Question 128Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A previously healthy 35-year-old with no comorbidities is treated as an outpatient for community-acquired pneumonia. Which antibiotic is an appropriate first-line choice?

    1. Ciprofloxacin
    2. Trimethoprim-sulfamethoxazole
    3. Clindamycin
    4. Amoxicillin Correct answer.

    Explanation

    For healthy adults without comorbidities, guideline-based outpatient options include high-dose amoxicillin or doxycycline, which cover the most likely pathogen, Streptococcus pneumoniae. Agents chosen for patients with comorbidities add coverage for resistant organisms and atypical pathogens. Ciprofloxacin lacks reliable pneumococcal activity.

  129. Question 129Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    An 82-year-old patient asks for a nonprescription sleep aid. Which agent is considered potentially inappropriate in older adults because of anticholinergic effects and next-day sedation?

    1. Diphenhydramine Correct answer.
    2. Cetirizine
    3. Acetaminophen
    4. Melatonin

    Explanation

    First-generation antihistamines such as diphenhydramine are listed as potentially inappropriate in older adults because of strong anticholinergic activity, confusion, urinary retention, and falls. Tolerance to the sedating effect develops quickly while the anticholinergic risk persists. Nonpharmacologic sleep hygiene measures are preferred.

  130. Question 130Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    An older adult started on sertraline 2 weeks ago develops confusion and unsteadiness. Which laboratory test most directly identifies a common cause of these new symptoms?

    1. Serum sodium Correct answer.
    2. Serum amylase
    3. Serum magnesium
    4. Serum phosphate

    Explanation

    Selective serotonin reuptake inhibitors can cause SIADH, producing hyponatremia most often within the first few weeks of therapy, and older adults are at highest risk. Symptoms range from nausea and confusion to seizures as sodium falls. Sodium should be checked promptly in a patient with new neurologic symptoms.

  131. Question 131Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with atrial fibrillation and a left ventricular ejection fraction of 30% requires ventricular rate control. Which agent is preferred?

    1. Verapamil
    2. Ivabradine
    3. Diltiazem
    4. Metoprolol succinate Correct answer.

    Explanation

    Beta-blockers are the preferred rate-control agents when left ventricular systolic function is reduced because they lack the negative inotropic effect that limits nondihydropyridine calcium channel blockers. Diltiazem and verapamil can precipitate decompensated heart failure in this setting. Digoxin is generally reserved as an add-on.

  132. Question 132Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A woman using a combined oral contraceptive is started on rifampin for tuberculosis. What counseling is most appropriate?

    1. Take two contraceptive pills daily while on rifampin
    2. No backup method is needed because rifampin does not affect hormones
    3. Use a backup barrier method during therapy and for 4 weeks afterward Correct answer.
    4. Stop the contraceptive and rely on withdrawal

    Explanation

    Rifampin is a potent inducer of CYP3A4 and increases hepatic and intestinal metabolism of ethinyl estradiol and progestins, lowering contraceptive concentrations. Induction persists for roughly 4 weeks after the last dose as enzyme levels return to baseline. Backup contraception should therefore continue through that washout period.

  133. Question 133Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A kidney transplant recipient maintained on azathioprine is started on allopurinol for gout. Which action is most appropriate?

    1. Continue both drugs at current doses with weekly blood counts
    2. Increase the azathioprine dose to offset the interaction
    3. Reduce the azathioprine dose substantially or avoid allopurinol Correct answer.
    4. Change allopurinol to a higher maintenance dose

    Explanation

    Allopurinol inhibits xanthine oxidase, the enzyme that normally clears the azathioprine metabolite 6-mercaptopurine. The result is a marked rise in 6-thioguanine nucleotides and potentially fatal myelosuppression. If both agents are essential, the azathioprine dose is cut drastically with frequent blood counts, but avoiding the combination is preferred.

  134. Question 134Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with cancer pain is stable on long-term morphine and also takes a benzodiazepine for anxiety. Which step best mitigates the risk of this combination?

    1. Offer take-home naloxone and counsel the patient on its use Correct answer.
    2. Add a standing stimulant to counteract sedation
    3. Limit morphine to a single daily dose
    4. Stop the benzodiazepine abruptly on the same day

    Explanation

    Concurrent opioid and benzodiazepine use multiplies the risk of fatal respiratory depression. Guidelines recommend offering naloxone to patients at increased risk and teaching the patient and a caregiver to recognize overdose and administer it. Abrupt benzodiazepine discontinuation risks withdrawal and seizures.

  135. Question 135Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A 3-year-old with acute otitis media and no penicillin allergy requires antibiotic therapy. Which agent is preferred first-line?

    1. Azithromycin
    2. Trimethoprim-sulfamethoxazole
    3. High-dose amoxicillin Correct answer.
    4. Cefdinir

    Explanation

    High-dose amoxicillin (80 to 90 mg/kg/day) provides reliable coverage of Streptococcus pneumoniae, including many penicillin-nonsusceptible strains, and is the recommended first-line agent. Cephalosporins are reserved for treatment failure or non-type-1 penicillin allergy. Macrolides and sulfonamides have high pneumococcal resistance rates.

  136. Question 136Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with normal renal function has a serum albumin of 2.0 g/dL and a total phenytoin concentration of 8 mcg/mL. Using the Sheiner-Tozer correction, what is the estimated corrected total phenytoin concentration?

    1. 8 mcg/mL
    2. 4 mcg/mL
    3. 12 mcg/mL
    4. 16 mcg/mL Correct answer.

    Explanation

    The corrected concentration equals the measured total concentration divided by (0.2 times albumin plus 0.1). Here 8 divided by (0.4 + 0.1) yields 16 mcg/mL, indicating the free fraction is much higher than the total value suggests. In hypoalbuminemia, therapeutic decisions should be based on the corrected value or a directly measured free level.

  137. Question 137Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which patient should be screened for HLA-B*1502 before starting carbamazepine?

    1. A patient of Northern European ancestry
    2. A patient with a documented penicillin allergy
    3. A patient with chronic kidney disease
    4. A patient of Han Chinese or Southeast Asian ancestry Correct answer.

    Explanation

    HLA-B*1502 is strongly associated with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis, and the allele is most prevalent in people of Han Chinese, Thai, and other Southeast Asian descent. Screening positive patients and avoiding carbamazepine markedly reduces this risk. The association is not clinically meaningful in most European populations.

  138. Question 138Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with a large aspirin overdose has metabolic acidosis and a rising salicylate concentration. Which intervention enhances salicylate elimination?

    1. Loop diuretic therapy to increase urine output alone
    2. Oral activated charcoal given 12 hours after ingestion
    3. Intravenous sodium bicarbonate to alkalinize the urine Correct answer.
    4. Intravenous ammonium chloride to acidify the urine

    Explanation

    Alkalinizing the urine with sodium bicarbonate traps the salicylate anion in the tubular lumen, since the ionized form cannot be reabsorbed, and also corrects the associated metabolic acidosis. Urinary alkalinization substantially increases renal clearance and reduces central nervous system penetration. Urine acidification has the opposite and harmful effect.

  139. Question 139Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient already taking valproate is about to begin lamotrigine. How should lamotrigine be initiated?

    1. Begin at a lower dose and titrate more slowly than usual Correct answer.
    2. Use the usual starting dose with the standard titration schedule
    3. Begin at twice the usual starting dose
    4. Use the usual starting dose but titrate more rapidly

    Explanation

    Valproate inhibits lamotrigine glucuronidation and roughly doubles lamotrigine concentrations, greatly increasing the risk of serious rash including Stevens-Johnson syndrome. The manufacturer specifies a much lower starting dose and a slower titration when valproate is co-prescribed. Enzyme inducers such as carbamazepine call for the opposite adjustment.

  140. Question 140Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A drug has a volume of distribution of 0.5 L/kg. What intravenous loading dose is needed to reach a target plasma concentration of 20 mg/L in a 70-kg patient, assuming negligible elimination during administration?

    1. 70 mg
    2. 700 mg Correct answer.
    3. 350 mg
    4. 1400 mg

    Explanation

    Loading dose equals volume of distribution times body weight times target concentration, so 0.5 L/kg times 70 kg times 20 mg/L equals 700 mg. The calculation assumes the drug distributes rapidly and that little is eliminated before distribution is complete. It is independent of clearance, which instead determines the maintenance dose.

  141. Question 141Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A hospitalized patient is receiving a continuous intravenous infusion of unfractionated heparin for venous thromboembolism. Which laboratory test is used to monitor the therapeutic effect?

    1. Platelet count
    2. INR
    3. Bleeding time
    4. aPTT Correct answer.

    Explanation

    Unfractionated heparin accelerates antithrombin activity, and the aPTT reflects this anticoagulant effect. It is the standard test for adjusting continuous intravenous heparin infusions.

  142. Question 142Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A man with stable angina asks about taking sildenafil. Which medication is absolutely contraindicated with sildenafil because of severe hypotension?

    1. Aspirin 81 mg
    2. Metoprolol succinate
    3. Nitroglycerin Correct answer.
    4. Atorvastatin calcium

    Explanation

    Nitrates and PDE5 inhibitors both increase cGMP-mediated vasodilation, and combining them can cause profound, refractory hypotension. Nitroglycerin is therefore contraindicated within 24 hours of sildenafil use.

  143. Question 143Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which instruction is most appropriate for a patient starting metformin for type 2 diabetes?

    1. Increase the dose rapidly to the maximum daily dose.
    2. Take with meals to reduce gastrointestinal upset. Correct answer.
    3. Take the dose at bedtime on an empty stomach.
    4. Stop the drug permanently if mild nausea occurs.

    Explanation

    Metformin commonly causes nausea and diarrhea, and taking it with meals plus gradual titration improves tolerance. Mild gastrointestinal upset does not require permanent discontinuation.

  144. Question 144Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with heart failure taking lisinopril and furosemide is started on spironolactone. Two weeks later, the potassium is 6.1 mEq/L and creatinine has risen. Which action is most appropriate?

    1. Hold spironolactone and lisinopril and arrange urgent evaluation Correct answer.
    2. Add potassium chloride supplementation and continue spironolactone
    3. Continue the current regimen and recheck potassium in one month
    4. Increase furosemide and continue spironolactone at the same dose

    Explanation

    An ACE inhibitor plus a mineralocorticoid receptor antagonist raises hyperkalemia risk, and a potassium of 6.1 mEq/L with worsening renal function is an emergency. Both offending drugs should be held while the patient is urgently evaluated.

  145. Question 145Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    Which medication is the preferred long-term controller for a patient with persistent asthma?

    1. Long-acting beta-2 agonist alone
    2. Inhaled corticosteroid Correct answer.
    3. Oral prednisone
    4. Inhaled ipratropium

    Explanation

    Inhaled corticosteroids are the preferred controller because they reduce airway inflammation and exacerbation risk. Long-acting beta-2 agonists are used only in combination with an inhaled corticosteroid in asthma.

  146. Question 146Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with heart failure and reduced ejection fraction has stable symptoms but reports lightheadedness. Blood pressure is 92/58 mm Hg, heart rate is 72 beats/min, lungs are clear, there is no edema, and weight is stable. Current medications are carvedilol, sacubitril/valsartan, spironolactone, and furosemide. Which adjustment is most appropriate?

    1. Reduce the furosemide dose Correct answer.
    2. Increase sacubitril/valsartan
    3. Add a potassium supplement
    4. Discontinue carvedilol immediately

    Explanation

    The patient has hypotension without congestion, suggesting excessive diuresis. Reducing furosemide is the safest first step while continuing guideline-directed heart failure therapy.

  147. Question 147Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient is prescribed levofloxacin for pneumonia. Which adverse effect should be included in counseling?

    1. Bradycardia and complete heart block
    2. Severe constipation that requires daily laxatives
    3. Tendon rupture, especially with corticosteroid use Correct answer.
    4. Persistent dry cough that resolves after stopping the drug

    Explanation

    Fluoroquinolones carry a boxed warning for tendinitis and tendon rupture, and risk is higher with concurrent corticosteroids, older age, and transplant. Patients should report tendon pain and stop the drug.

  148. Question 148Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient with type 2 diabetes and chronic kidney disease has an estimated glomerular filtration rate of 25 mL/min/1.73 m2. Which medication should be avoided?

    1. Insulin glargine
    2. Linagliptin
    3. Metformin Correct answer.
    4. Dapagliflozin

    Explanation

    Metformin is contraindicated when the eGFR is below 30 mL/min/1.73 m2 because of the risk of lactic acidosis. Alternative agents with safer renal profiles should be used.

  149. Question 149Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient taking digoxin develops vomiting and a serum potassium of 2.8 mEq/L. Which mechanism best explains the increased risk of digoxin toxicity?

    1. Hypokalemia increases renal clearance of digoxin and lowers its level
    2. Hypokalemia enhances digoxin binding to sodium-potassium ATPase Correct answer.
    3. Hypokalemia displaces digoxin from plasma protein binding sites
    4. Hypokalemia reduces intestinal absorption of digoxin

    Explanation

    Potassium competes with digoxin for binding at the sodium-potassium ATPase. Hypokalemia therefore increases digoxin binding and toxicity even at a therapeutic serum concentration.

  150. Question 150Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

    A patient taking dabigatran presents with life-threatening bleeding. Which agent is the specific reversal agent?

    1. Idarucizumab Correct answer.
    2. Vitamin K
    3. Protamine sulfate
    4. Fresh frozen plasma

    Explanation

    Idarucizumab is a monoclonal antibody fragment that binds dabigatran and reverses its anticoagulant effect. It is the specific agent for dabigatran-associated life-threatening bleeding.

  151. Question 151Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    In the Health Belief Model, a patient's estimate of how likely they are to develop a particular condition is called which construct?

    1. Cue to action
    2. Perceived susceptibility Correct answer.
    3. Self-efficacy
    4. Perceived severity

    Explanation

    Perceived susceptibility is the patient's belief about the chance of personally developing a health problem. Perceived severity concerns how serious the condition would be, cues to action are triggers, and self-efficacy is confidence in taking action.

  152. Question 152Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    Two intravenous antibiotics have identical cure rates and adverse-effect profiles, but their acquisition costs differ. Which pharmacoeconomic analysis is most appropriate?

    1. Cost-utility analysis
    2. Cost-effectiveness analysis
    3. Cost-minimization analysis Correct answer.
    4. Cost-benefit analysis

    Explanation

    Cost-minimization analysis is used when two or more interventions have been shown to produce equivalent clinical outcomes, so only their costs are compared. Cost-effectiveness and cost-utility analyses are used when outcomes differ, and cost-benefit analysis monetizes outcomes.

  153. Question 153Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    Which method is a direct measure of medication adherence?

    1. Serum drug concentration Correct answer.
    2. Patient self-report diary
    3. Pharmacy refill record review
    4. Pill count

    Explanation

    Direct adherence measures detect the drug or its marker in the body and include serum drug concentrations and directly observed therapy. Refill records, pill counts, and diaries are indirect because they infer adherence without confirming ingestion.

  154. Question 154Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    What is the primary purpose of a computerized prescriber order entry system?

    1. To allow prescribers to enter orders electronically Correct answer.
    2. To generate patient education handouts
    3. To store scanned paper medical records
    4. To automate pharmacy insurance claims

    Explanation

    Computerized prescriber order entry allows prescribers to enter medication and other orders directly into an electronic system, reducing handwriting and transcription errors. It may interface with other functions, but those are not its primary purpose.

  155. Question 155Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A community pharmacy learns that a large chain will open a store nearby. In a SWOT analysis, this development is best classified as which element?

    1. Strength
    2. Opportunity
    3. Weakness
    4. Threat Correct answer.

    Explanation

    A SWOT analysis separates internal strengths and weaknesses from external opportunities and threats. A new competitor is an external negative force, so it is classified as a threat.

  156. Question 156Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    In a pharmacoeconomic study spanning several years, future costs and health outcomes are discounted primarily because of which concept?

    1. A requirement limited to insurer perspectives
    2. General price inflation
    3. Time preference for present over future benefits Correct answer.
    4. The need to eliminate all uncertainty

    Explanation

    Discounting reflects time preference: resources and health benefits available now are generally valued more than equivalent ones in the future. It is distinct from inflation, which measures changes in prices.

  157. Question 157Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    Which action best illustrates the teach-back method during patient counseling?

    1. Repeating the instructions more quickly to save time
    2. Giving the patient a printed handout and asking for a signature
    3. Asking the patient to explain in their own words how to take the medicine Correct answer.
    4. Asking the patient whether the instructions are clear

    Explanation

    Teach-back confirms understanding by asking the patient to restate or demonstrate the information in their own words. A yes/no question or handout alone does not reliably show comprehension.

  158. Question 158Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    Medication reconciliation is best described as which process?

    1. Counting inventory to prevent stock shortages
    2. Comparing a patient's current medication list with new orders and resolving discrepancies Correct answer.
    3. Reviewing pharmacy claims to determine insurance coverage
    4. Checking whether prescription labels meet format standards

    Explanation

    Medication reconciliation is a formal process of obtaining an accurate medication list and comparing it with new orders to identify and resolve discrepancies. It is intended to prevent omissions, duplications, and dosing errors during transitions of care.

  159. Question 159Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A patient says, "I know I should start exercising, and I intend to begin within the next six months, but I have not taken any steps yet." Which stage of the transtheoretical model does this describe?

    1. Preparation
    2. Precontemplation
    3. Action
    4. Contemplation Correct answer.

    Explanation

    Contemplation is characterized by intention to change within the next six months without having taken meaningful action. Preparation involves intending to act soon and often taking small initial steps, while action involves recent behavior change.

  160. Question 160Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    Which pharmacist statement is most consistent with motivational interviewing?

    1. "What worries you most about taking this medicine?" Correct answer.
    2. "You missed doses because you were careless."
    3. "Just follow the handout and do not ask questions."
    4. "You must take this medicine every day or you will get worse."

    Explanation

    Motivational interviewing uses an empathic, collaborative style that evokes the patient's own reasons and concerns. Open-ended questions about the patient's worries support exploration rather than confrontation.

  161. Question 161Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    Which formula represents the incremental cost-effectiveness ratio when comparing a new treatment with a comparator?

    1. Incremental cost divided by incremental effect Correct answer.
    2. Incremental effect divided by incremental cost
    3. Total cost divided by total effect
    4. Total benefit minus total cost

    Explanation

    The incremental cost-effectiveness ratio divides the difference in cost between two alternatives by the difference in health effect. It expresses the additional cost required to gain one additional unit of outcome.

  162. Question 162Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A quality-adjusted life-year combines which two elements?

    1. Adverse events and patient satisfaction
    2. Length of life and health-related quality of life Correct answer.
    3. Direct medical costs and survival time
    4. Costs and caregiver burden

    Explanation

    A quality-adjusted life-year weights each period of survival by a utility value representing health-related quality of life. It therefore combines duration of life with quality of life into one outcome measure.

  163. Question 163Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A budget impact analysis is designed to estimate which of the following?

    1. Only the patient's out-of-pocket copayment
    2. The global burden of disease attributable to a drug class
    3. The financial consequences of adopting an intervention for a defined population over a specified period Correct answer.
    4. The cost per quality-adjusted life-year compared with placebo

    Explanation

    Budget impact analysis estimates the affordability of adopting a new intervention by projecting its financial effect on a payer or health system for a defined population and time horizon. It is distinct from cost-effectiveness analysis, which compares value per health outcome.

  164. Question 164Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    What is the main purpose of sensitivity analysis in a pharmacoeconomic evaluation?

    1. To calculate inflation adjustments automatically
    2. To eliminate all uncertainty from the model
    3. To test whether conclusions change when key assumptions vary Correct answer.
    4. To convert all outcomes into quality-adjusted life-years

    Explanation

    Sensitivity analysis examines how robust a result is by varying key assumptions, costs, or probabilities across plausible ranges. If conclusions remain stable, the analysis is more credible.

  165. Question 165Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    Which adherence metric is calculated as the number of days covered by medication divided by the number of days in the measurement period?

    1. Persistence
    2. Medication possession ratio
    3. Primary nonadherence
    4. Proportion of days covered Correct answer.

    Explanation

    Proportion of days covered counts the days on which medication is available in the measurement period and divides by total days. It is often capped at 1 and is commonly used in quality and outcomes assessment.

  166. Question 166Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A hospital wants to reduce alert fatigue from its clinical decision support system. Which strategy is most appropriate?

    1. Tier alerts by clinical severity and suppress low-value alerts Correct answer.
    2. Make each alert longer and more detailed
    3. Display every possible interaction at the same priority
    4. Remove all medication alerts from the system

    Explanation

    Alert fatigue is reduced by prioritizing alerts according to clinical importance and limiting low-value interruptions. Severity tiers help clinicians distinguish critical warnings from background information.

  167. Question 167Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    Which standard is designed to support exchange of healthcare data through web-based application programming interfaces?

    1. ICD-10
    2. NDC
    3. DSCSA
    4. FHIR Correct answer.

    Explanation

    Fast Healthcare Interoperability Resources, or FHIR, defines web-based resources and APIs for exchanging healthcare information. NDC identifies drug products, ICD-10 codes diagnoses, and DSCSA addresses drug supply chain security.

  168. Question 168Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A pharmacy department budgeted $100,000 in revenue but actually earned $105,000. How should this variance be described?

    1. Zero variance
    2. $5,000 unfavorable
    3. $105,000 favorable Correct answer.
    4. $5,000 favorable

    Explanation

    Revenue variance is actual revenue minus budgeted revenue, which is $105,000 minus $100,000, or $5,000. Because revenue exceeded the budget, the variance is favorable.

  169. Question 169Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    In failure mode and effects analysis, the risk priority number is calculated by multiplying which three factors?

    1. Severity, frequency, and cost
    2. Occurrence, cost, and patient satisfaction
    3. Detection, staffing, and volume
    4. Severity, occurrence, and detection Correct answer.

    Explanation

    The risk priority number in FMEA is the product of severity, occurrence, and detection scores. Higher scores identify failure modes that deserve priority for process improvement.

  170. Question 170Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    In ABC inventory analysis, which items are typically classified as class A?

    1. Obsolete items awaiting disposal
    2. Many low-cost items with little effect on total inventory value
    3. High-dollar-value items requiring tight inventory control Correct answer.
    4. Controlled substances stored in a vault

    Explanation

    ABC analysis classifies inventory by annual dollar usage. Class A items account for a large share of total value and therefore receive the tightest monitoring and control.

  171. Question 171Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A pharmacist is counseling a patient with limited health literacy. Which action is most appropriate?

    1. Provide a dense paragraph of technical instructions
    2. Use plain language and pictures to explain key instructions Correct answer.
    3. Use medical terminology to ensure precision
    4. Ask only yes-or-no questions to confirm understanding

    Explanation

    Plain language, visual aids, and chunking information support comprehension for patients with limited health literacy. Confirmation should use teach-back rather than yes-or-no questions alone.

  172. Question 172Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A patient learns to use an insulin pen by watching a video of another patient demonstrate the technique. Which social cognitive theory construct does this best illustrate?

    1. Reinforcement
    2. Behavioral capability
    3. Self-efficacy
    4. Observational learning Correct answer.

    Explanation

    Observational learning occurs when a person acquires a behavior by watching others perform it. Self-efficacy is confidence, behavioral capability is knowledge and skill, and reinforcement is a consequence that affects repetition.

  173. Question 173Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    In a just culture, which response to a medication error is most appropriate?

    1. Examine system causes while holding individuals accountable for reckless behavior Correct answer.
    2. Discipline every staff member who was on duty
    3. Blame the last person who handled the medication
    4. Conceal the error to avoid liability

    Explanation

    A just culture distinguishes human error from reckless conduct and emphasizes system improvement while maintaining appropriate individual accountability. It encourages reporting and learning rather than blame.

  174. Question 174Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A new drug costs $60,000 more than standard therapy and produces 2 additional quality-adjusted life-years. If the payer's willingness-to-pay threshold is $50,000 per quality-adjusted life-year, how should the drug be interpreted?

    1. It is not cost-effective at any threshold
    2. It is cost-effective only below $20,000 per quality-adjusted life-year
    3. It is cost-effective at a $50,000 per quality-adjusted life-year threshold Correct answer.
    4. It is dominated by standard therapy

    Explanation

    The incremental cost-effectiveness ratio is $60,000 divided by 2 quality-adjusted life-years, or $30,000 per quality-adjusted life-year. Because $30,000 is below the $50,000 willingness-to-pay threshold, the drug is considered cost-effective under that threshold.

  175. Question 175Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A wellness program costs $200,000 and produces $260,000 in monetized benefits. Which interpretation is correct?

    1. The benefit-cost ratio is 0.77 and the program is not worthwhile
    2. No conclusion can be drawn because benefits are monetized
    3. The program has a positive net benefit and a benefit-cost ratio greater than 1 Correct answer.
    4. The program has a negative net benefit and should be rejected

    Explanation

    Net benefit equals monetized benefits minus costs, or $60,000. The benefit-cost ratio is $260,000 divided by $200,000, or 1.3, which is greater than 1 and indicates positive economic value in this analysis.

  176. Question 176Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A pharmacoeconomic evaluation counts medical costs together with the value of patients' lost wages and unpaid caregiver time. Which analytic perspective does this approach represent?

    1. Societal perspective Correct answer.
    2. Third-party payer perspective
    3. Hospital administrator perspective
    4. Patient out-of-pocket perspective

    Explanation

    The societal perspective counts every cost and benefit of an intervention regardless of who bears it, so it is the only perspective that routinely includes indirect costs such as lost productivity and caregiver time. Narrower perspectives capture only the costs falling on that specific stakeholder.

  177. Question 177Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    An investigator estimates the total annual direct medical costs and productivity losses caused by rheumatoid arthritis in a region, without comparing any treatment alternatives. Which type of analysis is this?

    1. Cost-benefit analysis
    2. Cost-utility analysis
    3. Cost-minimization analysis
    4. Cost-of-illness analysis Correct answer.

    Explanation

    A cost-of-illness analysis quantifies the economic burden of a disease and by design does not compare competing interventions. Comparative designs such as cost-minimization, cost-benefit, and cost-utility analyses all require at least two alternatives with measured consequences.

  178. Question 178Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A hospital pharmacy reports the percentage of eligible inpatients who received a pneumococcal vaccination before discharge. This indicator is best classified as which type of quality measure?

    1. An outcome measure
    2. A structural measure
    3. A balancing measure
    4. A process measure Correct answer.

    Explanation

    Process measures describe whether a recommended action was actually delivered to eligible patients, which is exactly what a vaccination-before-discharge rate captures. Outcome measures reflect the resulting health status, structural measures describe resources and organization, and balancing measures detect unintended consequences of improvement efforts.

  179. Question 179Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A pharmacy director restructures the department so that every employee receives work direction from one designated supervisor only, eliminating conflicting instructions. Which management principle does this illustrate?

    1. Unity of command Correct answer.
    2. Decentralization
    3. Span of control
    4. Division of labor

    Explanation

    Unity of command holds that each employee should report to a single supervisor so that authority and accountability are unambiguous. Span of control concerns how many subordinates one manager can effectively oversee, division of labor concerns task specialization, and decentralization concerns where decision authority resides.

  180. Question 180Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics)

    A pharmacy reports annual cost of goods sold of $1,200,000 and an average inventory value of $150,000. Which interpretation of its inventory turnover is correct?

    1. Inventory is sold and replaced about 8 times per year Correct answer.
    2. Inventory turns over about 0.125 times per year, indicating excess stock
    3. Inventory turns over about 8 times per day, indicating rapid replenishment
    4. Inventory turns over about 80 times per year, indicating chronic stockouts

    Explanation

    Inventory turnover equals cost of goods sold divided by average inventory, so $1,200,000 divided by $150,000 gives 8 turns per year, meaning the average inventory is consumed and restocked roughly eight times annually. Comparisons to benchmarks for similar pharmacies then reveal whether stock is excessive or too lean.

  181. Question 181Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    Under the federal Controlled Substances Act, which statement describes refills of a Schedule II prescription?

    1. They may be refilled once with prescriber authorization.
    2. They may be refilled up to five times within six months.
    3. They may be refilled indefinitely if the prescriber indicates.
    4. They may not be refilled under any circumstances. Correct answer.

    Explanation

    Federal law prohibits refilling a Schedule II prescription; each dispensing requires a new prescription, apart from narrowly defined emergency oral orders and specific federal exceptions. The five-refills-in-six-months allowance applies to Schedule III and IV prescriptions, not Schedule II.

  182. Question 182Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    Which statement best describes the HIPAA minimum necessary standard?

    1. It applies only to paper records and not to electronic health information.
    2. It requires reasonable efforts to limit protected health information to the amount needed for the purpose. Correct answer.
    3. It applies to every use and disclosure of protected health information without exception.
    4. It permits disclosure of the entire record whenever a family member asks about the patient.

    Explanation

    The minimum necessary standard requires covered entities to make reasonable efforts to limit protected health information to what is needed to accomplish the intended purpose. Important exceptions exist, including disclosures for treatment, disclosures to the individual, and disclosures required by law.

  183. Question 183Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    The Omnibus Budget Reconciliation Act of 1990 addressed pharmacist counseling. Which obligation did it create at the federal level?

    1. An obligation to counsel only when a patient asks for it.
    2. An obligation to provide written counseling for every new prescription.
    3. An obligation to offer counseling to Medicaid patients. Correct answer.
    4. An obligation to counsel every patient under a federal statute.

    Explanation

    OBRA-90 requires that Medicaid recipients be offered counseling by the pharmacist as a condition of Medicaid payment. Most states subsequently broadened the requirement through state law or board rules so that all patients must be offered counseling.

  184. Question 184Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A generic product carries an "AB" therapeutic equivalence rating in the FDA Orange Book. What does this rating indicate?

    1. It is an authorized generic distributed by the brand manufacturer.
    2. It is therapeutically equivalent to the reference listed drug. Correct answer.
    3. It has unresolved bioequivalence problems requiring further study.
    4. It is approved for a different indication than the brand product.

    Explanation

    In the Orange Book coding system, the first letter indicates whether actual or potential bioequivalence problems have been resolved; an "A" code means the product is considered therapeutically equivalent and is generally substitutable. The second letter "B" denotes that the equivalence was established by adequate in vivo or in vitro evidence.

  185. Question 185Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    Which element is essential to valid informed consent for drug therapy?

    1. Documentation of the patient's insurance coverage
    2. A witness present during the discussion
    3. A signed liability waiver from the patient
    4. Voluntary consent after adequate disclosure Correct answer.

    Explanation

    Informed consent rests on decision-making capacity, adequate disclosure of risks, benefits, and alternatives, comprehension by the patient, and voluntariness. Written documentation is useful evidence but is not the ethical essence of consent.

  186. Question 186Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A nonsterile compounded preparation contains no water. Under USP General Chapter <795>, what is its default beyond-use date?

    1. 180 days Correct answer.
    2. 1 year
    3. 14 days when stored refrigerated
    4. 30 days

    Explanation

    USP <795> assigns default beyond-use dates according to the type of preparation: 180 days for nonaqueous dosage forms, 14 days refrigerated for water-containing oral preparations, and 30 days for other water-containing topical, dermal, and mucosal liquids. The assigned date may be shortened by the expiration date of a component or by the container system.

  187. Question 187Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A community pharmacy purchases a Schedule II controlled substance from its wholesaler. Which ordering practice is correct?

    1. The pharmacy submits a DEA Form 222 or uses CSOS for each order. Correct answer.
    2. The pharmacy uses a photocopy of a previously executed DEA Form 222.
    3. The pharmacy orders by invoice and files the invoice as the receipt record.
    4. The pharmacy orders by telephone and confirms in writing within seven days.

    Explanation

    Schedule II procurement requires a DEA Form 222 or an approved electronic CSOS order, and the executed order forms must be retained as records of receipt. The forms are controlled documents that cannot be photocopied, altered, or erased; an error voids the form and requires a new one.

  188. Question 188Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A patient relocates and asks a new pharmacy to transfer her prescription for a non-controlled medication. Which statement is correct?

    1. Transfers are prohibited unless the prescriber issues a new prescription.
    2. Both pharmacies document the transfer after the patient authorizes it. Correct answer.
    3. Transfers are permitted only between pharmacies in the same state.
    4. The prescription may be transferred only if refills remain.

    Explanation

    Prescription transfer is governed primarily by state law, and most states permit transfer with patient authorization, with both the transferring and receiving pharmacy retaining documentation. For controlled substances, DEA rules permit a one-time transfer of an unfilled electronic prescription for initial filling between registered retail pharmacies.

  189. Question 189Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A hospital pharmacy and therapeutics committee authorizes pharmacists to substitute one proton pump inhibitor for another when the prescribed agent is not on formulary. This practice is best described as:

    1. Therapeutic interchange Correct answer.
    2. Generic substitution
    3. Therapeutic duplication
    4. Pharmaceutical care

    Explanation

    Therapeutic interchange replaces a prescribed agent with a chemically different drug in the same therapeutic class under an approved protocol. Generic substitution, by contrast, replaces a brand product with a therapeutically equivalent product containing the same active ingredient.

  190. Question 190Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A prescriber writes an order for "MS 10 mg PO q.d." What is the most appropriate pharmacist response?

    1. Dispense magnesium sulfate, since ambiguity should be resolved toward the safer drug.
    2. The order may be interpreted as written because both abbreviations remain in common use.
    3. Dispense morphine sulfate, since MS conventionally denotes morphine in most settings.
    4. Contact the prescriber for clarification before dispensing. Correct answer.

    Explanation

    "MS" is on the ISMP list of error-prone abbreviations because it can mean morphine sulfate or magnesium sulfate, and "q.d." can be misread as "q.i.d." The pharmacist must clarify the intended drug and frequency with the prescriber before any dispensing occurs.

  191. Question 191Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A pharmacist suspects that a newly marketed drug caused a serious, unexpected adverse event. What is the most appropriate action?

    1. Wait for a second occurrence before submitting a report.
    2. Report the event only in the annual quality improvement review.
    3. Report the event to the DEA as a diversion concern.
    4. Report the event to FDA MedWatch and to the manufacturer. Correct answer.

    Explanation

    MedWatch is the FDA program for reporting serious adverse events and product problems, and health professionals are encouraged to report promptly. Manufacturers hold a mandatory obligation to report serious and unexpected adverse events to FDA, so notifying them is also appropriate.

  192. Question 192Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A medication is subject to a Risk Evaluation and Mitigation Strategy that includes elements to assure safe use. Which statement is correct?

    1. It may be dispensed without a prescription once the strategy is approved.
    2. It is exempt from child-resistant packaging requirements.
    3. The requirements apply only to investigational drugs.
    4. Only certified pharmacies may dispense it to eligible patients. Correct answer.

    Explanation

    When a strategy includes elements to assure safe use, dispensing is restricted to certified pharmacies and prescribers and to patients who meet specified conditions, such as laboratory monitoring or enrollment in a registry. The strategy adds safeguards; it does not remove the prescription requirement.

  193. Question 193Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    Under the Poison Prevention Packaging Act, which circumstance supports dispensing a prescription in a non-child-resistant container?

    1. The medication is a controlled substance stored in the home.
    2. The patient or the prescriber requests non-child-resistant packaging. Correct answer.
    3. The pharmacy has temporarily run out of child-resistant containers.
    4. The patient is older than 65 years and lives independently.

    Explanation

    The Poison Prevention Packaging Act permits noncomplying packaging when the prescriber directs it or when the patient requests it, and the request should be documented per pharmacy policy. A shortage of child-resistant stock is not a recognized basis for dispensing noncomplying containers.

  194. Question 194Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A pharmacist has a conscientious objection to dispensing a particular legally prescribed medication. Which action is most consistent with professional ethics and applicable law?

    1. Refuse without discussion and return the prescription to the patient.
    2. Dispense the medication regardless of the pharmacist's beliefs.
    3. Refer or transfer the patient promptly to another source of care. Correct answer.
    4. Hold the prescription on file indefinitely without notifying the patient.

    Explanation

    Professional guidance and most state rules allow a pharmacist to decline on moral grounds only when the patient's access is preserved, typically through prompt referral or transfer. The duty to avoid abandonment means the patient must be informed and helped to obtain the medication.

  195. Question 195Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A state requires prescribers and dispensers to participate in a prescription drug monitoring program. What does this typically require of a pharmacist?

    1. Report only Schedule II dispensing to the PDMP.
    2. Query the PDMP as required by state law before dispensing. Correct answer.
    3. Share PDMP data with any family member who requests it.
    4. Query the PDMP for every prescription, including antibiotics.

    Explanation

    State PDMP statutes specify when a dispenser must review the database, commonly before dispensing an opioid or other monitored controlled substance, and what must be reported after dispensing. Reporting obligations typically cover a broad set of scheduled substances rather than Schedule II alone.

  196. Question 196Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    Which activity best exemplifies pharmaceutical care rather than traditional dispensing?

    1. Resolving a drug therapy problem with the prescriber Correct answer.
    2. Counting tablets and applying the prescription label accurately
    3. Submitting claims to a third-party payer for reimbursement
    4. Verifying that the controlled substance inventory is complete

    Explanation

    Pharmaceutical care is the responsible provision of drug therapy to achieve definite outcomes that improve a patient's quality of life, which requires identifying and resolving drug therapy problems in collaboration with the patient and prescriber. Product preparation and administrative tasks support this purpose but are not its defining activity.

  197. Question 197Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    How does a 503B outsourcing facility differ from a 503A traditional compounding pharmacy?

    1. Both types of compounders are exempt from USP standards.
    2. A 503A pharmacy may compound copies of commercially available drug products for its own stock.
    3. A 503B facility follows cGMP and may compound without patient-specific prescriptions. Correct answer.
    4. A 503B facility is not required to register with the FDA.

    Explanation

    A 503B outsourcing facility must register with FDA, comply with current good manufacturing practice, and may compound without patient-specific prescriptions, subject to reporting and other requirements. A 503A pharmacy compounds for identified patients pursuant to valid prescriptions and may not routinely compound essentially copies of commercially available products.

  198. Question 198Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A hospital pharmacy designates a buyer to order Schedule II controlled substances from its wholesaler. Which statement is correct?

    1. The power of attorney may be granted verbally by the pharmacist-in-charge.
    2. The buyer must obtain a separate DEA registration in the hospital's name.
    3. Any licensed pharmacist may sign Schedule II order forms without any written documentation.
    4. The registrant may execute a power of attorney for the buyer to sign orders. Correct answer.

    Explanation

    The registered purchaser may execute a power of attorney authorizing a named individual to sign DEA Form 222 orders, and the power of attorney must be retained with the executed order forms and available for inspection. Under CSOS, a comparable electronic power of attorney is used.

  199. Question 199Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    A manufacturer provides detailed risk information to prescribers but does not communicate directly with patients. Under the learned intermediary doctrine:

    1. The pharmacist bears sole liability for any injury the patient suffers.
    2. The manufacturer's duty is met by adequately warning the prescriber. Correct answer.
    3. The doctrine eliminates the manufacturer's duty to warn anyone.
    4. The manufacturer is strictly liable for injury regardless of the warning given.

    Explanation

    The learned intermediary doctrine holds that a manufacturer discharges its duty to warn by giving adequate information to the prescribing clinician, who then exercises judgment for the individual patient. The doctrine does not eliminate the duty; it directs the warning to the prescriber.

  200. Question 200Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

    Which requirement applies to a pharmacy handling a drug on the NIOSH hazardous drug list?

    1. Containment strategies, PPE, and documented procedures are required. Correct answer.
    2. Hazardous drugs may be stored with other stock if containers are labeled.
    3. Pregnant staff should prepare all hazardous drugs to build immunity.
    4. Hazardous drug waste may be discarded in the regular trash.

    Explanation

    USP General Chapter <800> requires containment strategies such as closed-system transfer devices and appropriate personal protective equipment, along with a documented assessment of risk and written policies and procedures. Hazardous drug waste must be handled and disposed of under hazardous waste requirements.

FPGEE flashcards

32 cards. Read the term and the definition here. The deck at the top of this page is optional.

Henderson-Hasselbalch equation
For a weak acid, pH = pKa + log([A−]/[HA]); for a weak base, pH = pKa + log([B]/[BH+]). It predicts the ionized versus un-ionized fraction at a given pH.
Volume of distribution
Vd equals the amount of drug in the body divided by plasma concentration. A large Vd indicates extensive tissue binding or distribution, which limits removal by hemodialysis.
Drug clearance
Clearance is the volume of plasma cleared of drug per unit time. After an intravenous dose, CL = dose/AUC, and it determines maintenance dosing at steady state.
Oral bioavailability
F is the fraction of an administered dose reaching systemic circulation intact. It is calculated as (AUCoral × doseIV)/(AUCIV × doseoral) and is reduced by first-pass metabolism.
Elimination half-life
t1/2 = 0.693 × Vd/CL. It is the time for plasma concentration to fall by half; approximately four to five half-lives are needed to reach steady state.
First-pass metabolism
Presystemic metabolism of an orally absorbed drug in the intestinal wall or liver before it reaches systemic circulation, lowering oral bioavailability. Intravenous, sublingual, and transdermal routes bypass it.
Minimum inhibitory concentration
The lowest antimicrobial concentration that prevents visible growth of a standardized bacterial inoculum. It is used with PK/PD indices such as time above MIC or AUC/MIC.
Therapeutic index
TI = TD50/ED50, the ratio of toxic to effective dose. A larger index indicates a wider margin of safety; narrow-index drugs require therapeutic drug monitoring.
Competitive antagonist
Binds reversibly at the same receptor site as the agonist, shifting the dose-response curve right and raising EC50 without changing maximal efficacy; high agonist concentrations can overcome it.
Noncompetitive antagonist
Binds at a site other than the agonist binding site or irreversibly, reducing maximal efficacy (Emax) and potentially potency; increasing agonist concentration cannot fully reverse it.
Zero-order elimination
A constant amount of drug is eliminated per unit time because metabolic pathways are saturated. Half-life increases with concentration; examples include phenytoin, ethanol, and high-dose aspirin.
CYP3A4 inhibitors
Drugs or foods that decrease CYP3A4 activity and raise levels of CYP3A4 substrates. Examples include ketoconazole, clarithromycin, ritonavir, and grapefruit juice.
Prodrug
An inactive compound converted in vivo by metabolism to an active drug. Examples include enalapril to enalaprilat and codeine to morphine.
N-acetylcysteine antidote
A glutathione precursor used to treat acetaminophen overdose. It replenishes hepatic glutathione and detoxifies the reactive metabolite NAPQI, especially when given early.
Vancomycin AUC/MIC target
For serious MRSA infections, the target AUC24/MIC is 400–600. AUC-guided dosing is preferred over trough-only monitoring to balance efficacy and nephrotoxicity.
Warfarin INR targets
Most atrial fibrillation and venous thromboembolism indications target INR 2.0–3.0. A mechanical mitral valve typically requires INR 2.5–3.5.
Metformin first-line therapy
Metformin is first-line pharmacotherapy for type 2 diabetes unless contraindicated. It is avoided when eGFR is below 30 mL/min/1.73 m² because of lactic acidosis risk.
Heart failure GDMT
Guideline-directed therapy for HFrEF combines an ARNI, ACE inhibitor, or ARB with a beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitor to reduce mortality.
Cockcroft-Gault equation
Estimates creatinine clearance: [(140 − age) × weight in kg]/[72 × serum creatinine in mg/dL], multiplied by 0.85 for women. It is commonly used for renal dose adjustment.
CHA2DS2-VASc score
Estimates stroke risk in nonvalvular atrial fibrillation using congestive heart failure, hypertension, age, diabetes, stroke, vascular disease, and sex; higher scores favor anticoagulation.
Beers Criteria
A list of potentially inappropriate medications for adults aged 65 and older, organized by drug class and clinical concern, used to reduce adverse drug events.
Incremental cost-effectiveness ratio
ICER = (cost of intervention − cost of comparator)/(effect of intervention − effect of comparator). It expresses the added cost per additional health outcome, such as per QALY gained.
Quality-adjusted life year
A QALY equals one year in perfect health. It is calculated as time in a health state multiplied by a utility weight from 0 (death) to 1 (perfect health).
Cost-minimization analysis
A pharmacoeconomic method used when two treatments are assumed to have equivalent clinical outcomes; only costs are compared to identify the less expensive option.
Sensitivity analysis
A method that varies key model inputs, such as costs or probabilities, to test whether economic conclusions remain robust under uncertainty. One-way and probabilistic approaches are common.
Transtheoretical model
Describes behavior change across precontemplation, contemplation, preparation, action, and maintenance stages. Interventions are matched to the patient's current stage of readiness.
ABC inventory analysis
Classifies inventory by annual value: class A items are about 20% of items but 80% of value and receive the tightest purchasing and control oversight.
Durham-Humphrey Amendment
The 1951 amendment created the prescription versus over-the-counter distinction and authorized oral prescriptions and refills for certain non-controlled medications.
Controlled Substances Act
The 1970 federal law created schedules I through V based on abuse potential and accepted medical use, and established DEA registration and recordkeeping requirements.
Schedule II refills
Schedule II prescriptions may not be refilled; a new prescription is required. Emergency oral prescriptions require a written or electronic follow-up within seven days.
OBRA-90 counseling
Federal Medicaid law requiring pharmacists to offer counseling and maintain patient records, supporting prospective drug utilization review and pharmaceutical care documentation.
USP 797
United States Pharmacopeia chapter setting standards for sterile compounding, including facility design, environmental monitoring, personnel training, and beyond-use dating.

FPGEE study guide

Basic Biomedical and Pharmaceutical Sciences

Core science map

Biochemistry questions cluster around enzyme kinetics (Km, Vmax, competitive vs noncompetitive inhibition), rate-limiting steps of glycolysis and the TCA cycle, oxidative phosphorylation, and vitamin cofactors. Molecular biology expects the central dogma, PCR, restriction enzymes, mutations, and the difference between replication, transcription, and translation. Immunology expects innate vs adaptive immunity, MHC class I vs II, immunoglobulin classes, complement, hypersensitivity types, and vaccine types. Microbiology expects bacterial cell-wall structure (Gram-positive, Gram-negative, mycobacteria), resistance mechanisms (beta-lactamases, efflux pumps, ribosomal methylation), and the distinction between sterilization, disinfection, and antisepsis.

Pharmaceutics and pharmacokinetics

Know the core equations: t½ = 0.693 × Vd/CL; loading dose = (Vd × target concentration)/F; maintenance rate = (CL × target concentration)/F. Distinguish first-order from zero-order elimination, and remember that half-life changes when either Vd or CL changes. Bioavailability, salt factor, protein binding, and first-pass metabolism are frequent traps. Questions often test whether a dose adjustment is based on renal function, hepatic function, or body size.

Traps and rule of thumb

Do not confuse Vd with plasma volume; a large Vd means extensive tissue distribution, not a large blood pool. Watch units (mg vs mcg) and whether the question asks for a loading dose or a maintenance rate. Rule of thumb: steady state is reached in about 4–5 half-lives, and roughly 97% of steady state is achieved by then.

Worked example

A 70-kg patient has Vd = 0.5 L/kg (35 L), target concentration 2 mg/L, and F = 1. Loading dose = 35 L × 2 mg/L = 70 mg. If CL = 3.5 L/h, maintenance rate = 3.5 L/h × 2 mg/L = 7 mg/h.

Pharmacology, Medicinal Chemistry, and Toxicology

Receptor pharmacology

Master the vocabulary of affinity, intrinsic activity, potency, and efficacy. Full agonists have both affinity and full intrinsic activity; partial agonists have affinity but submaximal efficacy; competitive antagonists have affinity and zero efficacy; inverse agonists reduce constitutive activity. On dose-response curves, a competitive antagonist shifts the agonist curve right without lowering Emax, while a noncompetitive antagonist lowers Emax. Potency is measured by EC50 or Kd; efficacy by Emax.

Medicinal chemistry and metabolism

Know the pharmacophore concept, structure-activity relationships, bioisosteres, prodrugs, and stereochemistry. Ionization and pKa determine absorption and distribution; a drug must be sufficiently lipid-soluble to cross membranes but sufficiently soluble to dissolve. Phase I reactions (oxidation, reduction, hydrolysis) often introduce or expose functional groups; phase II reactions (glucuronidation, sulfation, acetylation, methylation, glutathione conjugation) increase water solubility. CYP induction lowers drug levels; CYP inhibition raises them. Prodrugs require metabolic activation, so inhibitors of that activation can reduce efficacy.

Toxicology

Recognize classic toxidromes: anticholinergic (dry, flushed, tachycardic, delirium), cholinergic (SLUDGE/DUMBELS), opioid (miosis, respiratory depression), sympathomimetic, and serotonin syndrome. Know antidotes: N-acetylcysteine for acetaminophen, naloxone for opioids, flumazenil for benzodiazepines (caution), sodium bicarbonate for salicylates, fomepizole or ethanol for methanol/ethylene glycol, and chelators for heavy metals. Zero-order drugs (ethanol, phenytoin, salicylate at high doses) do not have a constant half-life.

Rule of thumb

Affinity drives potency; intrinsic activity drives efficacy. If a question asks whether Emax changes, ask whether the antagonist can be overcome by more agonist.

Worked example

A drug has EC50 = 10 nM and Emax = 100%. A competitive antagonist shifts EC50 to 100 nM but Emax remains 100%; a noncompetitive antagonist leaves EC50 similar but reduces Emax to 40%.

Clinical Pharmacy and Pharmacotherapy

Patient assessment and monitoring

Clinical questions reward a systematic approach: subjective and objective data, assessment, and plan (SOAP). Build a problem list, then link each problem to guideline-based therapy, goals of therapy, and monitoring parameters. Know how to estimate renal function with the Cockcroft-Gault equation: CrCl = [(140 − age) × weight]/(72 × SCr), multiplied by 0.85 for women. Know when to use actual, ideal, or adjusted body weight. Recognize common monitoring traps: CBC for clozapine and methotrexate, LFTs for methotrexate and statins, TSH for amiodarone, digoxin levels for toxicity, and vancomycin AUC rather than trough alone.

Therapeutics and safety

High-yield areas include anticoagulation (INR for warfarin, anti-Xa for heparins), heart failure, diabetes, asthma/COPD, infectious disease, and pain management. Apply the Beers criteria for older adults and deprescribing principles. Evaluate adverse drug events with causality tools such as the Naranjo scale. Drug interactions, duplication, and adherence barriers are common question stems.

Drug information

Use primary, secondary, and tertiary literature appropriately; appraise study design, bias, and generalizability. Off-label use requires evidence and documentation.

Traps

Do not adjust doses for renal function using serum creatinine alone without considering age, weight, and sex. Do not confuse trough and peak levels. Do not assume a sliding-scale insulin regimen is basal insulin.

Worked example

A 70-year-old woman weighs 60 kg and has SCr 1.2 mg/dL. CrCl = [(140 − 70) × 60]/(72 × 1.2) × 0.85 ≈ 41 mL/min. Use this to select renally adjusted doses and avoid nephrotoxic combinations.

Social, Behavioral, Administrative, and Economic Pharmacy Sciences

Pharmacoeconomics

Know the four main analyses: cost-minimization (outcomes assumed equal), cost-effectiveness (cost per natural unit, such as cost per life-year), cost-utility (cost per QALY), and cost-benefit (all costs and outcomes in dollars). The incremental cost-effectiveness ratio (ICER) = (cost new − cost old)/(effect new − effect old). If a new therapy is more effective and less costly, it dominates. Perspective matters: societal, payer, and patient perspectives include different costs. Discount future costs and outcomes, and test assumptions with sensitivity analysis. Budget impact differs from cost-effectiveness.

Outcomes and adherence

Distinguish clinical, humanistic, and economic outcomes. Adherence measures include medication possession ratio (MPR) and proportion of days covered (PDC). Quality-of-life instruments include EQ-5D and SF-36. Health literacy, beliefs, and social determinants shape behavior.

Management and informatics

Understand organizational structure, leadership, staffing, inventory control (ABC analysis, just-in-time), continuous quality improvement (PDSA), and SWOT analysis. Informatics concepts include EHRs, CPOE, clinical decision support, barcode medication administration, e-prescribing, interoperability (HL7/FHIR), and HIPAA privacy rules. Alert fatigue is a major implementation trap.

Traps

Do not compare a cost-benefit ratio in dollars with a cost-effectiveness ratio in dollars per QALY. Do not ignore the perspective when comparing studies. Do not discount costs in the first year.

Worked example

New drug costs $10,000 and yields 2.0 QALYs; old drug costs $6,000 and yields 1.5 QALYs. ICER = ($10,000 − $6,000)/(2.0 − 1.5) = $4,000/0.5 = $8,000 per QALY.

Pharmacy Practice, Law, and Ethics

Jurisprudence and controlled substances

Pharmacy law is a layered system: federal statutes set a floor, and state boards of pharmacy may impose stricter rules. Know the Controlled Substances Act schedules. Schedule II drugs have high abuse potential and no refills; a partial fill is allowed if the pharmacist cannot supply the remainder within 72 hours, while patient- or prescriber-requested partial fills must be completed within 30 days under federal rules. Schedule III–V drugs have refill limits and expiration rules. Know DEA Form 222 for Schedule II ordering, PDMP use, REMS, and DSCSA tracking requirements. Prescription validity, required elements, transfer rules, and record retention are frequent test items.

Compounding and dispensing

Distinguish compounding from manufacturing. Pharmacists may not routinely compound copies of commercially available products. USP <795> covers nonsterile compounding, <797> sterile compounding, and <800> hazardous drugs. Beyond-use dates differ from manufacturer expiration dates. Dispensing requires accurate labeling, patient counseling, and error reporting.

Ethics and pharmaceutical care

Apply autonomy, beneficence, nonmaleficence, and justice. Address conflicts between patient welfare and business pressure, informed consent, privacy under HIPAA (minimum necessary), and duty to warn. Medication error reporting should be nonpunitive and systems-based.

Traps

Do not assume a Schedule II prescription is valid indefinitely; state rules vary. Do not use a manufacturer expiration date as a beyond-use date. Do not counsel by disclosing protected information without need.

Rule of thumb

When federal and state law conflict, follow the stricter requirement; when ethics conflict, prioritize patient safety and informed choice.

FPGEE cheat sheet

Quick reference

Basic Biomedical and Pharmaceutical Sciences

  • Henderson–Hasselbalch: for a weak acid, pH = pKa + log([A−]/[HA]); for a weak base, pH = pKa + log([B]/[BH+]).

  • Volume of distribution Vd = amount of drug in body / plasma concentration; loading dose = (Vd × target concentration) / F.

  • Clearance CL = dose / AUC; elimination half-life t1/2 = 0.693 × Vd / CL; steady state is reached in about 4–5 half-lives.

  • Oral bioavailability F = (AUC_oral × dose_IV) / (AUC_IV × dose_oral); first-pass metabolism lowers F for orally administered drugs.

  • Zero-order elimination removes a constant amount per unit time; half-life increases as concentration rises (phenytoin, ethanol, high-dose aspirin).

  • MIC is the lowest antimicrobial concentration that inhibits visible growth; PK/PD indices include time above MIC (beta-lactams), AUC/MIC (vancomycin), and Cmax/MIC (aminoglycosides).

  • Gram-positive bacteria have a thick peptidoglycan layer; gram-negative bacteria have an outer membrane; beta-lactams inhibit penicillin-binding protein transpeptidation.

  • IgM is the first antibody produced in a primary response, IgG is the most abundant serum immunoglobulin, IgA predominates in mucosa, and IgE mediates mast-cell degranulation.

  • Bacterial protein synthesis inhibitors bind the 30S subunit (aminoglycosides, tetracyclines) or the 50S subunit (macrolides, clindamycin, chloramphenicol).

Quick reference

Pharmacology, Medicinal Chemistry, and Toxicology

  • Potency is reflected by EC50 (lower EC50 = greater potency); efficacy is reflected by Emax.

  • Competitive antagonists shift the dose-response curve right and increase EC50 without changing Emax; noncompetitive antagonists reduce Emax.

  • Therapeutic index TI = TD50 / ED50; a larger TI indicates a wider margin between toxic and effective doses.

  • Phase I metabolism uses oxidation, reduction, and hydrolysis, often by CYP450; phase II metabolism conjugates drugs via glucuronidation, sulfation, acetylation, or glutathione.

  • CYP3A4 inhibitors include ketoconazole, clarithromycin, ritonavir, and grapefruit; inducers include rifampin, carbamazepine, phenytoin, and St. John's wort.

  • Prodrugs are inactive until metabolized in vivo; examples include enalapril to enalaprilat and codeine to morphine.

  • Antidotes: N-acetylcysteine for acetaminophen, naloxone for opioids, flumazenil for benzodiazepines, fomepizole for methanol or ethylene glycol, deferoxamine for iron, pralidoxime for organophosphates.

  • For narrow-therapeutic-index drugs, small dose increases can produce large level increases when elimination is saturated (phenytoin, theophylline, lithium).

  • Enantiomers can differ in activity and clearance; examples include S-warfarin (more potent) and S-omeprazole (more active).

Quick reference

Clinical Pharmacy and Pharmacotherapy

  • Cockcroft–Gault creatinine clearance = [(140 − age) × weight kg] / [72 × serum creatinine mg/dL], multiplied by 0.85 for women.

  • Warfarin INR target is 2.0–3.0 for most atrial fibrillation and venous thromboembolism indications; mechanical mitral valves often target 2.5–3.5.

  • For serious MRSA infections, vancomycin AUC24/MIC target is 400–600; AUC-guided monitoring is preferred over trough-only monitoring.

  • Metformin is first-line for type 2 diabetes unless contraindicated; avoid initiation when eGFR is below 45 and contraindicate below 30 mL/min/1.73 m².

  • HFrEF guideline-directed therapy combines an ARNI, ACE inhibitor, or ARB with a beta-blocker, mineralocorticoid receptor antagonist, and SGLT2 inhibitor.

  • CHA2DS2-VASc estimates stroke risk in nonvalvular atrial fibrillation; higher scores support anticoagulation after bleeding-risk assessment.

  • Beers Criteria identify potentially inappropriate medications for adults aged 65 and older, including benzodiazepines, anticholinergics, and certain NSAIDs.

  • High-intensity statin therapy (atorvastatin 40–80 mg or rosuvastatin 20–40 mg) is used for established atherosclerotic cardiovascular disease.

  • HbA1c target is below 7% for most nonpregnant adults with diabetes, individualized for hypoglycemia risk, comorbidity, and life expectancy.

Quick reference

Social, Behavioral, Administrative, and Economic Pharmacy Sciences

  • Incremental cost-effectiveness ratio ICER = (Cost_A − Cost_B) / (Effect_A − Effect_B); compare with a willingness-to-pay threshold.

  • Cost-minimization analysis assumes equivalent outcomes and compares only costs; cost-benefit analysis values outcomes in monetary units; cost-utility analysis uses QALYs.

  • QALY = years of life × utility weight, where 0 represents death and 1 represents perfect health.

  • Future costs and health outcomes are discounted, commonly at 3% per year, in economic evaluations.

  • Sensitivity analysis varies model inputs to test whether economic conclusions remain robust under uncertainty.

  • Transtheoretical model stages are precontemplation, contemplation, preparation, action, and maintenance; interventions are matched to stage.

  • ABC inventory analysis classifies items by annual dollar value; class A items are roughly 20% of items but about 80% of value and require tight control.

  • Health belief model constructs include perceived susceptibility, perceived severity, perceived benefits, perceived barriers, and cues to action.

  • NCPDP and HL7 are interoperability standards used for pharmacy claims, e-prescribing, and health information exchange.

Quick reference

Pharmacy Practice, Law, and Ethics

  • The Food, Drug, and Cosmetic Act of 1938 required premarket safety evidence; the Durham-Humphrey Amendment of 1951 created prescription versus over-the-counter status.

  • The Kefauver-Harris Amendment of 1962 required proof of efficacy and informed consent for clinical investigation.

  • The Controlled Substances Act of 1970 created schedules I–V based on abuse potential and accepted medical use, with DEA registration and recordkeeping.

  • Schedule II prescriptions cannot be refilled; emergency oral Schedule II prescriptions require written or electronic follow-up within seven days.

  • OBRA-90 requires Medicaid pharmacists to offer counseling and maintain patient records, supporting prospective drug utilization review.

  • HIPAA Privacy Rule protects protected health information and applies the minimum-necessary standard to disclosures.

  • USP <797> sets sterile compounding standards; USP <800> sets handling standards for hazardous drugs.

  • 503A compounding pharmacies compound for individual prescriptions; 503B outsourcing facilities follow cGMP and adverse-event reporting requirements.

  • The Drug Supply Chain Security Act requires product tracing, verification, and serialization for prescription drugs.

FPGEE key terms

Bioavailability

The fraction of an administered dose of a drug that reaches the systemic circulation unchanged, expressed as a percentage. Intravenous administration is defined as 100 percent; oral values are lower when absorption or first-pass metabolism limits entry.

Related: First-pass metabolism, Bioequivalence
Volume of distribution

A calculated apparent volume relating the total amount of drug in the body to its plasma concentration. Large values suggest extensive distribution into tissues; small values suggest the drug remains largely in the bloodstream.

Related: Loading dose, Clearance
Clearance

The volume of plasma from which a drug is completely removed per unit time. It determines the maintenance dose rate needed to sustain a target steady-state concentration, independent of the volume of distribution.

Related: Steady state, Elimination half-life
Elimination half-life

The time required for the plasma concentration of a drug to fall by half during elimination. It reflects the ratio of volume of distribution to clearance and governs how quickly a drug accumulates or disappears.

Related: Steady state, Clearance
First-pass metabolism

Breakdown of an orally absorbed drug by enzymes in the intestinal wall or liver before it reaches the systemic circulation, reducing oral bioavailability and often requiring larger oral than intravenous doses.

Related: Bioavailability, Cytochrome P450 induction
Steady state

The condition during repeated dosing when the amount of drug entering the body equals the amount eliminated per dosing interval, so concentrations fluctuate around a stable average, typically reached after four to five half-lives.

Related: Loading dose, Clearance
Loading dose

An initial larger dose given to raise plasma drug concentrations rapidly toward a therapeutic target, calculated from the volume of distribution and the desired concentration rather than from clearance.

Related: Volume of distribution, Steady state
Bioequivalence

The demonstration that two drug products deliver the same active ingredient into the bloodstream at a comparable rate and extent, usually assessed by comparing total exposure and peak concentration within accepted statistical limits.

Related: Bioavailability
Minimum inhibitory concentration

The lowest concentration of an antimicrobial agent that prevents visible growth of a standardized bacterial inoculum under defined laboratory conditions, used to classify organisms as susceptible, intermediate, or resistant.

Opsonization

Coating of a pathogen with antibodies or complement proteins so that phagocytic cells recognize and engulf it more efficiently, linking humoral immunity to cellular clearance of microbes.

Surfactant

An amphiphilic molecule with both water-loving and fat-loving regions that lowers interfacial tension, allowing oils and water to mix and stabilizing emulsions, suspensions, and powder wetting.

Michaelis-Menten kinetics

The description of saturable drug elimination in which clearance is roughly first order at low concentrations but approaches a fixed maximum rate at high concentrations, so small dose increases can cause disproportionate accumulation.

Related: Clearance, Elimination half-life
Pharmacophore

The specific three-dimensional arrangement of chemical features in a molecule that is required for biological activity at a target, serving as a template for designing new active compounds.

Related: Structure-activity relationship, Log P
Structure-activity relationship

The study of how systematic changes in a molecule's chemical structure alter its potency, selectivity, and safety, used to guide optimization of lead compounds into drug candidates.

Related: Pharmacophore, Log P
Partial agonist

A ligand that binds and activates a receptor but produces a smaller maximal response than a full agonist, and can reduce the effect of a full agonist when both are present.

Related: Competitive antagonist
Competitive antagonist

A ligand that binds reversibly at the same site as the agonist, produces no activation, and shifts the agonist dose-response curve to the right without lowering the maximal response.

Related: Partial agonist, Therapeutic index
Therapeutic index

A ratio comparing the dose producing toxicity with the dose producing the desired effect; a small ratio means therapeutic and toxic doses are close, requiring cautious dosing and monitoring.

Related: Therapeutic drug monitoring
Cytochrome P450 induction

An increase in liver enzyme production after repeated exposure to a drug or chemical, which speeds metabolism of the inducing agent and of other drugs, lowering their concentrations and possibly their effectiveness.

Related: First-pass metabolism, Therapeutic drug monitoring
Chelating agent

A molecule that binds metal ions at multiple sites to form a stable ring-shaped complex, used to treat heavy-metal poisoning by promoting urinary excretion of the metal.

Log P

The logarithm of a compound's partition coefficient between octanol and water, a measure of lipophilicity that predicts membrane permeability, tissue distribution, and metabolic behavior.

Related: Pharmacophore, Structure-activity relationship
Tachyphylaxis

Rapid loss of a drug's effect after repeated doses over a short period, often from depletion of mediators or receptor desensitization, and distinct from slower-developing tolerance.

Related: Partial agonist
Therapeutic drug monitoring

Measurement of drug concentrations in blood with interpretation to individualize dosing, used for drugs with narrow therapeutic ranges, unpredictable pharmacokinetics, or concentration-related toxicity.

Related: Therapeutic index, Adverse drug reaction
Adverse drug reaction

An unintended, harmful response to a medicine used at normal doses, ranging from predictable dose-related effects to unpredictable immune or idiosyncratic reactions that require dose change or discontinuation.

Related: Pharmacovigilance, Black box warning
Black box warning

The strongest safety warning required by regulators on a prescription drug's labeling, highlighting serious or life-threatening risks and shaping prescribing, monitoring, and patient counseling decisions.

Related: Adverse drug reaction
Off-label use

Prescribing an approved medicine for a dose, indication, patient population, or route not covered by its regulatory approval, a lawful practice that should rest on sound published evidence.

Related: Clinical practice guideline
Clinical practice guideline

Systematically developed statements that recommend appropriate treatment for specific clinical circumstances, synthesized from evidence and expert judgment to standardize and improve patient care.

Related: Off-label use, Number needed to treat
Number needed to treat

The number of patients who must receive an intervention for one additional patient to benefit, calculated as the reciprocal of the absolute risk reduction; smaller values indicate greater benefit.

Related: Quality-adjusted life year, Incremental cost-effectiveness ratio
Quality-adjusted life year

A measure combining length of life with health-related quality of life, in which one year in perfect health equals one; used to compare value across treatments and inform resource allocation.

Related: Incremental cost-effectiveness ratio
Incremental cost-effectiveness ratio

The ratio of the difference in cost between two interventions to the difference in their health outcomes, commonly expressed as the added cost per quality-adjusted life year gained.

Related: Quality-adjusted life year, Formulary
Formulary

A continually updated list of medicines approved for use within a health system, maintained by a committee that evaluates efficacy, safety, and cost to guide prescribing decisions.

Related: Incremental cost-effectiveness ratio
Medication adherence

The extent to which a patient takes medicines as agreed with the prescriber, including timing, dose, and duration; poor adherence is a common and modifiable cause of treatment failure.

Related: Medication reconciliation, Pharmaceutical care
Medication reconciliation

A structured process of comparing a patient's complete medication list across care transitions and resolving discrepancies to prevent omissions, duplications, and dosing errors.

Related: Pharmaceutical care, Medication adherence
Pharmaceutical care

A patient-centered practice model in which the pharmacist accepts responsibility for identifying and resolving drug-related problems and for achieving definite outcomes that improve the patient's quality of life.

Related: Medication reconciliation, Medication adherence
Informed consent

A patient's voluntary agreement to a treatment or service after receiving and understanding information about its purpose, benefits, risks, and alternatives, documented in the health record.

Beyond-use date

The date after which a compounded preparation must not be used, assigned from stability data and based on the formulation, container, storage conditions, and water content.

Tall man lettering

A labeling convention that capitalizes the distinguishing parts of look-alike drug names, such as hydrOXYzine versus hydrALAZINE, to reduce selection and dispensing errors.

Related: Medication reconciliation
Pharmacovigilance

The science of detecting, assessing, understanding, and preventing adverse effects or other drug-related problems, relying on spontaneous reporting systems and postmarketing surveillance data.

Related: Adverse drug reaction, Black box warning

FPGEE study plan

8 weeks · About 8 hours per week

Week 1

Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

  • Diagram carbohydrate, lipid, and amino acid metabolic pathways from memory, labeling rate-limiting enzymes and regulatory points

  • Recite the steps of DNA replication, transcription, and translation, then correct gaps against a reference text

  • Differentiate bacterial, viral, and fungal structural features and match each to a drug target class

  • Distinguish innate from adaptive immunity and state one clinical correlate for each immunoglobulin class

Your checkpoint

A one-page hand-drawn metabolic and molecular-biology concept map plus a 25-item self-quiz scored at or above 80%.

Week 2

Basic Biomedical and Pharmaceutical Sciences (biochemistry, microbiology, immunology, molecular biology, pharmaceutics, pharmacokinetics)

  • Calculate volume of distribution, clearance, half-life, and AUC from supplied plasma concentration data

  • Contrast zero-order and first-order elimination and predict drug accumulation under repeated dosing

  • Classify dosage forms and explain excipient roles and biopharmaceutic factors governing absorption

  • Solve loading-dose, maintenance-dose, and renal-adjustment calculations with dimensional analysis shown

Your checkpoint

A worked problem set of 20 pharmacokinetic calculations with step-by-step solutions, at least 90% correct.

Week 3

Pharmacology, Medicinal Chemistry, and Toxicology

  • Build a receptor-family table (GPCR, ion channel, enzyme-linked, nuclear) populated with agonist and antagonist drug examples

  • Trace signal transduction for adrenergic, cholinergic, and opioid receptors and predict downstream effects

  • Apply structure-activity relationship principles to explain potency and selectivity differences within two drug classes

  • Identify common toxidromes, match each to its antidote, and state the antidote's mechanism

Your checkpoint

A consolidated receptor and toxidrome reference table plus 40 practice items scored at or above 75%.

Week 4

Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information) & Pharmacology, Medicinal Chemistry, and Toxicology

  • Select first-line therapy and monitoring parameters for hypertension, heart failure, and dyslipidemia using a systematic framework

  • Interpret hemoglobin A1c, lipid panel, serum creatinine, INR, and electrolyte values to adjust drug regimens

  • Explain mechanisms and management strategies for major adverse drug events in cardiovascular pharmacotherapy

  • Compose counseling points for anticoagulants and antiplatelet agents that address bleeding precautions and adherence

Your checkpoint

Four written patient cases in SOAP format with justified regimens, monitoring plans, and counseling notes.

Week 5

Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

  • Design therapeutic plans with measurable endpoints for diabetes, thyroid disorders, and asthma/COPD

  • Justify empiric antibiotic selection by site of infection, likely organism, and local resistance patterns

  • Rank drug interactions within a polypharmacy profile by severity and defend each recommended intervention

  • Differentiate guideline-endorsed from contraindicated therapy in renal and hepatic impairment

Your checkpoint

A severity-ranked drug-interaction review of a synthetic 12-medication patient profile with recommendations.

Week 6

Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

  • Formulate monitoring plans for psychiatric, neurologic, and pain-management regimens including labs and adverse-effect surveillance

  • Apply pharmacokinetic and pharmacodynamic principles to pediatric, pregnant, and older adult patients

  • Critique trial abstracts for internal validity, effect size, and applicability to a defined patient

  • Write SOAP notes that state therapeutic endpoints in measurable terms

Your checkpoint

Two complete SOAP notes plus a one-page critical appraisal of a randomized controlled trial.

Week 7

Social, Behavioral, Administrative, and Economic Pharmacy Sciences (management, pharmacoeconomics, health outcomes, informatics) & Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care)

  • Compare cost-effectiveness, cost-utility, and cost-benefit analyses and interpret an incremental cost-effectiveness ratio

  • Describe formulary management, pharmacy benefit manager functions, and medication therapy management documentation and billing

  • Apply controlled-substance schedules, refill limits, and record-retention requirements to dispensing scenarios

  • Apply an ethical decision framework to dispensing and conflict-of-interest dilemmas

Your checkpoint

A one-page pharmacoeconomic critique of a published cost-effectiveness study plus a 30-item law and ethics quiz scored at or above 80%.

Week 8

Pharmacy Practice, Law, and Ethics (pharmacy jurisprudence, compounding, dispensing, and pharmaceutical care) & Clinical Pharmacy and Pharmacotherapy (therapeutics, patient assessment, monitoring, and drug information)

  • Perform sterile and nonsterile compounding calculations and assign beyond-use dates from USP standards

  • Map the dispensing workflow and specify error-prevention checks and federally required counseling points

  • Complete two full-length timed mock exams and classify every missed item by domain and subtopic

  • Assemble a one-page high-yield summary sheet for each of the five domains

Your checkpoint

Two completed mock exams with an error-analysis log and a written remediation plan targeting the three weakest subtopics.

Milestones

Week 2: Explain metabolic, molecular, and pharmacokinetic fundamentals aloud for 20 minutes without notes and score at least 80% on a 30-item Domain 1 quiz.

Week 4: Score at least 70% on a 60-item mixed quiz covering Domains 1 and 2 and resolve every missed item with a written rationale.

Week 6: Score at least 70% on a 100-item timed practice exam weighted to Domains 1 through 3, with at least 65% in Domain 3 alone.

Week 8: Achieve at least 75% overall on two full-length mock exams and document a remediation plan for any domain below 65%.

FPGEE exam day

Your checklist

Government-issued photo ID with signature

Bring a valid driver's license, state ID, or passport. The name must match your NABP registration exactly, including middle names and suffixes. If your name has legally changed, contact NABP well before test day to update your record; an expired or unsigned ID will be refused at check-in.

Appointment confirmation / eligibility record

Have your testing appointment confirmation and NABP identification number available. Confirm with NABP or the test vendor whether a printed confirmation is required or whether an electronic copy is acceptable at your specific center.

Plan to arrive 30+ minutes early

Check-in involves ID verification, a photograph, and a rules briefing. Arriving late can result in being turned away and losing your seat fee. Build in buffer for traffic, parking, and building security screening.

Verified test center address, parking, and route

Do a dry run or map the route the day before. Identify parking or transit options and the exact building entrance, since testing centers inside office parks or university campuses can be hard to locate.

Leave prohibited items at home

Phones, smartwatches, fitness trackers, earbuds, bags, notes, and study materials are not allowed in the testing room. Most centers provide a small locker; anything that does not fit may not be accommodated. Confirm your center's storage policy in advance.

Comfort layers and eyeglasses

Testing rooms are often cold, and you will be seated for long blocks. Wear layers you can adjust. If you wear contacts, consider bringing glasses as a backup for long screen sessions.

Snack and water for the break

Bring a light, familiar snack and water to leave in your locker for the scheduled break. Avoid heavy or unfamiliar food. Confirm whether the break allows access to your locker at your center.

Confirm any approved testing accommodations

If you requested extra time, a separate room, or other accommodations, verify in writing that they were approved and will be in place. Unapproved accommodations cannot be granted on test day.

Read the NABP candidate handbook and test center rules

Review the current handbook for the exam format, timing, break policy, ID requirements, and score reporting before test day so nothing at check-in is a surprise.

Confirm the current exam format

Verify the number of items, number of testing blocks, and total seated time from your NABP appointment materials, since exam structure and delivery logistics are periodically updated.

Practice the pacing math once

Divide total testing minutes by the number of items on your confirmation to get your target per-item pace, and rehearse holding it during at least one full-length practice set before test day.

Rest and a normal morning routine

Protect sleep in the 48 hours before the exam and eat a normal breakfast. Cramming new material the night before reliably costs more in fatigue than it gains in recall.

Plan the day

72 hours before

Print or save your appointment confirmation, re-read the NABP handbook sections on ID, prohibited items, and breaks, and physically set aside your ID and comfort items in one place. Stop starting new content areas.

72 hours before

Do one timed, full-length or half-length practice set at the same time of day as your real appointment to calibrate pacing and stamina, then review only your error patterns, not new topics.

24 hours before

Confirm the test center address, route, and travel time, and decide your departure time. Check the weather and any transit disruptions. Pack your bag with ID, confirmation, snack, and layers.

24 hours before

Limit review to a short pass over high-yield lists and formulas you already know. Avoid alcohol and screens late; set two alarms; aim for a full night's sleep.

Morning of

Eat a normal breakfast, hydrate moderately, dress in layers, and leave with buffer time. Leave your phone and study materials at home or in the car if your center's storage is limited.

At check-in

Present your ID, complete photo and verification steps, store all personal items in the locker, use the restroom, and read the on-screen instructions before the clock starts.

During the test

Work at your rehearsed per-item pace. Answer every item, flag long or uncertain ones, and move on rather than sinking time into a single question.

During the test

Take the offered break: stand, stretch, drink water, and eat your snack, then return promptly. Confirm before test day whether break time counts against your exam clock.

Final minutes of each block

Use remaining time to clear flags and confirm no item is left blank. Do not change answers on a hunch unless you can point to a specific reason.

After the test

Note any irregularity or equipment problem to the proctor before you leave, and keep your score report and any documentation with your records.

Rules to check

  • Your ID name must match your NABP registration exactly. Name discrepancies or expired documents can result in being denied entry; contact NABP before test day to correct your record.

  • No personal belongings, notes, or electronic devices are permitted in the testing room. Lockers, if provided, are for storage only and access is limited to the break.

  • Scratch material, if provided by the test center, must be returned or accounted for at the end of the session and may not be removed from the room. Confirm the specific scratch-material policy with the provider.

  • Break timing varies by center and exam. Confirm with NABP and your test center whether breaks are scheduled or unscheduled and whether break time is deducted from your testing time, then plan bathroom and snack timing accordingly.

  • Answer every question. Unanswered items score as incorrect, and there is no benefit to leaving an item blank instead of making an educated choice.

  • Results are reported as a scaled score against a passing standard set by NABP. Confirm the current passing standard and score-report timing with NABP; any on-screen indication at the center is not the official result.

  • Exam content is confidential. Communicating, publishing, or reconstructing exam items is prohibited and can lead to score invalidation or other sanctions.

  • Follow all proctor instructions, including seating, room entry and exit, and sign-out procedures. Suspected misconduct or irregular behavior may result in a cancelled score and a report to the board.

FPGEE FAQ

How many FPGEE practice questions are available?

The practice set has 200 FPGEE questions. Each one includes the choices, the correct answer, and an explanation, and the set is free to read with no signup.

How many FPGEE flashcards are available?

The flashcard set has 32 FPGEE cards. Each card shows the term and its definition.

Which topics does the FPGEE study material cover?

The FPGEE study material has 5 sections, including Basic Biomedical and Pharmaceutical Sciences, Pharmacology, Medicinal Chemistry, and Toxicology, and Clinical Pharmacy and Pharmacotherapy.

What format facts does the catalog list for the FPGEE exam?

The catalog lists these item types: multiple choice for the FPGEE exam.